Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Herbert Meltzer

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Living Beings

Rats

Activities & Behaviors

Schizophrenic Psychology

Concepts & Ideas

Anatomy

Blood Platelets

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Meltzer Herbert Y; Dritselis Argyris; Yasothan Uma; Kirkpatrick Peter
Asenapine.
Bebbington Paul E; Cooper Claudia; Minot Sarah; Brugha Traolach S; Jenkins Rachel; Meltzer Howard; Dennis Michael
Suicide attempts, gender, and sexual abuse: data from the 2000 British Psychiatric Morbidity Survey.
Zai Clement C; Tiwari Arun K; King Nicole; De Luca Vincenzo; Mueller Daniel J; Shaikh Sajid; Wong Greg W H; Meltzer Herbert Y; Lieberman Jeffrey A; Kennedy James L
Association study of the gamma-aminobutyric acid type a receptor gamma2 subunit gene with schizophrenia.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Herbert Meltzer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Meltzer Herbert Y; Dritselis Argyris; Yasothan Uma; Kirkpatrick Peter
Asenapine.
Nature reviews. Drug discovery 2009;8(11):843-4.
2009: Bebbington Paul E; Cooper Claudia; Minot Sarah; Brugha Traolach S; Jenkins Rachel; Meltzer Howard; Dennis Michael
Suicide attempts, gender, and sexual abuse: data from the 2000 British Psychiatric Morbidity Survey.
The American journal of psychiatry 2009;166(10):1135-40.
2009: Zai Clement C; Tiwari Arun K; King Nicole; De Luca Vincenzo; Mueller Daniel J; Shaikh Sajid; Wong Greg W H; Meltzer Herbert Y; Lieberman Jeffrey A; Kennedy James L
Association study of the gamma-aminobutyric acid type a receptor gamma2 subunit gene with schizophrenia.
Schizophrenia research 2009;114(1-3):33-8.
2009: Kaneda Yasuhiro; Jayathilak Karuna; Meltzer Herbert Y
Determinants of work outcome in schizophrenia and schizoaffective disorder: role of cognitive function.
Psychiatry research 2009;169(2):178-9.
2009: Meltzer David O; Basu Anirban; Meltzer Herbert Y
Comparative effectiveness research for antipsychotic medications: how much is enough?
Health affairs (Project Hope) 2009;28(5):w794-808.
2009: Li Zhu; Prus Adam J; Dai Jin; Meltzer Herbert Y
Differential effects of M1 and 5-hydroxytryptamine1A receptors on atypical antipsychotic drug-induced dopamine efflux in the medial prefrontal cortex.
The Journal of pharmacology and experimental therapeutics 2009;330(3):948-55.
2009: Sickert Laertes; Müller Daniel J; Tiwari Arun K; Shaikh Sajid; Zai Clement; De Souza Renan; De Luca Vincenzo; Meltzer Herbert Y; Lieberman Jeffrey A; Kennedy James L
Association of the alpha2A adrenergic receptor -1291C/G polymorphism and antipsychotic-induced weight gain in European-Americans.
Pharmacogenomics 2009;10(7):1169-76.
2009: Bobo William V; Jayathilake Karuna; Lee Myung A; Meltzer Herbert Y
Melperone, an aytpical antipsychotic drug with clozapine-like effect on plasma prolactin: contrast with typical neuroleptics.
Human psychopharmacology 2009;24(5):415-22.
2009: Abbas Atheir I; Hedlund Peter B; Huang Xi-Ping; Tran Thuy B; Meltzer Herbert Y; Roth Bryan L
Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo.
Psychopharmacology 2009;205(1):119-28.
2009: Kessler Robert M; Woodward Neil D; Riccardi Patrizia; Li Rui; Ansari M Sib; Anderson Sharlett; Dawant Benoit; Zald David; Meltzer Herbert Y
Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects.
Biological psychiatry 2009;65(12):1024-31.
2009: Zai C C; Tiwari A K; Basile V; De Luca V; Müller D J; King N; Voineskos A N; Remington G; Meltzer H Y; Lieberman J A; Potkin S G; Kennedy J L
Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients.
The pharmacogenomics journal 2009;9(3):168-74.
2009: De Luca Vincenzo; Souza Renan P; Viggiano Emanuella; Zai Clement C; Shinkai Takahiro; Lieberman Jeffrey A; Potkin Steve G; Meltzer Herbert Y; Remington Gary; Kennedy James L
MDR1 gene in tardive dyskinesia scale scores: comparison of strategies for quantitative trait haplotype analysis.
Schizophrenia research 2009;110(1-3):200-1.
2009: Zai Clement C; Tiwari Arun K; De Luca Vincenzo; Müller Daniel J; Bulgin Natalie; Hwang Rudi; Zai Gwyneth C; King Nicole; Voineskos Aristotle N; Meltzer Herbert Y; Lieberman Jeffrey A; Potkin Steven G; Remington Gary; Kennedy James L
Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2009;19(5):317-28.
2009: Philibin Scott D; Walentiny D Matthew; Vunck Sarah A; Prus Adam J; Meltzer Herbert Y; Porter Joseph H
Further characterization of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in C57BL/6 mice: role of 5-HT(2A) serotonergic and alpha (1) adrenergic antagonism.
Psychopharmacology 2009;203(2):303-15.
2009: Meltzer Herbert Y
Atypical antipsychotic drugs have their merits.
Lancet 2009;373(9668):1007; author reply 1007-8.
2009: Szewczyk Bernadeta; Albert Paul R; Burns Ariel M; Czesak Margaret; Overholser James C; Jurjus George J; Meltzer Herbert Y; Konick Lisa C; Dieter Lesa; Herbst Nicole; May Warren; Rajkowska Grazyna; Stockmeier Craig A; Austin Mark C
Gender-specific decrease in NUDR and 5-HT1A receptor proteins in the prefrontal cortex of subjects with major depressive disorder.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2009;12(2):155-68.
2009: Need Anna C; Ge Dongliang; Weale Michael E; Maia Jessica; Feng Sheng; Heinzen Erin L; Shianna Kevin V; Yoon Woohyun; Kasperaviciute Dalia; Gennarelli Massimo; Strittmatter Warren J; Bonvicini Cristian; Rossi Giuseppe; Jayathilake Karu; Cola Philip A; McEvoy Joseph P; Keefe Richard S E; Fisher Elizabeth M C; St Jean Pamela L; Giegling Ina; Hartmann Annette M; Möller Hans-Jürgen; Ruppert Andreas; Fraser Gillian; Crombie Caroline; Middleton Lefkos T; St Clair David; Roses Allen D; Muglia Pierandrea; Francks Clyde; Rujescu Dan; Meltzer Herbert Y; Goldstein David B
A genome-wide investigation of SNPs and CNVs in schizophrenia.
PLoS genetics 2009;5(2):e1000373.
2009: Geffen Yona; Nudelman Abraham; Gil-Ad Irit; Rephaeli Ada; Huang Mei; Savitsky Kinneret; Klapper Leah; Winkler Ilan; Meltzer Herbert Y; Weizman Abraham
BL-1020: a novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2009;19(1):1-13.
2008: Zai Clement C; Romano-Silva Marco A; Hwang Rudi; Zai Gwyneth C; Deluca Vincenzo; Müller Daniel J; King Nicole; Voineskos Aristotle N; Meltzer Herbert Y; Lieberman Jeffrey A; Potkin Steven G; Remington Gary; Kennedy James L
Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia.
Schizophrenia research 2008;106(2-3):248-52.
2008: Meltzer Herbert Y; Brennan Mark D; Woodward Neil D; Jayathilake Karu
Association of Sult4A1 SNPs with psychopathology and cognition in patients with schizophrenia or schizoaffective disorder.
Schizophrenia research 2008;106(2-3):258-64.
2008: Meltzer Herbert Y; Sumiyoshi Tomiki
Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia?
Behavioural brain research 2008;195(1):98-102.
2008: Huang Mei; Li Zhu; Dai Jin; Shahid Mohammed; Wong Erik H F; Meltzer Herbert Y
Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(12):2934-45.
2008: Meltzer Herbert Y
Oakley Ray, 1931-2007.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(11):2783-4.
2008: Ayer David W; Jayathilake Karu; Meltzer Herbert Y
The InterSePT suicide scale for prediction of imminent suicidal behaviors.
Psychiatry research 2008;161(1):87-96.
2008: Li Zhu; Snigdha Shikha; Roseman Alex S; Dai Jin; Meltzer Herbert Y
Effect of muscarinic receptor agonists xanomeline and sabcomeline on acetylcholine and dopamine efflux in the rat brain; comparison with effects of 4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one (AC260584) and N-desmethylclozapine.
European journal of pharmacology 2008;596(1-3):89-97.
2008: Souza Renan P; Romano-Silva Marco A; Lieberman Jeffrey A; Meltzer Herbert Y; Wong Albert H C; Kennedy James L
Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response.
Psychopharmacology 2008;200(2):177-86.
2008: Lieberman Jeffrey A; Bymaster Frank P; Meltzer Herbert Y; Deutch Ariel Y; Duncan Gary E; Marx Christine E; Aprille June R; Dwyer Donard S; Li Xin-Min; Mahadik Sahebarao P; Duman Ronald S; Porter Joseph H; Modica-Napolitano Josephine S; Newton Samuel S; Csernansky John G
Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.
Pharmacological reviews 2008;60(3):358-403.
2008: Kinon Bruce J; Volavka Jan; Stauffer Virginia; Edwards Sara E; Liu-Seifert Hong; Chen Lei; Adams David H; Lindenmayer Jean-Pierre; McEvoy Joseph P; Buckley Peter F; Lieberman Jeffrey A; Meltzer Herbert Y; Wilson Daniel R; Citrome Leslie
Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study.
Journal of clinical psychopharmacology 2008;28(4):392-400.
2008: Meltzer Herbert Y; Bobo William V; Nuamah Isaac F; Lane Rosanne; Hough David; Kramer Michelle; Eerdekens Marielle
Efficacy and tolerability of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 6-week, placebo-controlled studies.
The Journal of clinical psychiatry 2008;69(5):817-29.
2008: Keefe Richard S E; Malhotra Anil K; Meltzer Herbert Y; Kane John M; Buchanan Robert W; Murthy Anita; Sovel Mindy; Li Chunming; Goldman Robert
Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(6):1217-28.
2008: Krystal John H; Carter Cameron S; Geschwind Daniel; Manji Husseini K; March John S; Nestler Eric J; Zubieta Jon-Kar; Charney Dennis S; Goldman David; Gur Raquel E; Lieberman Jeffrey A; Roy-Byrne Peter; Rubinow David R; Anderson Stewart A; Barondes Samuel; Berman Karen F; Blair James; Braff David L; Brown E Sherwood; Calabrese Joseph R; Carlezon William A; Cook Edwin H; Davidson Richard J; Davis Michael; Desimone Robert; Drevets Wayne C; Duman Ronald S; Essock Susan M; Faraone Stephen V; Freedman Robert; Friston Karl J; Gelernter Joel; Geller Barbara; Gill Michael; Gould Elizabeth; Grace Anthony A; Grillon Christian; Gueorguieva Ralitza; Hariri Ahmad R; Innis Robert B; Jones Edward G; Kleinman Joel E; Koob George F; Krystal Andrew D; Leibenluft Ellen; Levinson Douglas F; Levitt Pat R; Lewis David A; Liberzon Israel; Lipska Barbara K; Marder Stephen R; Markou Athina; Mason Graeme F; McDougle Christopher J; McEwen Bruce S; McMahon Francis J; Meaney Michael J; Meltzer Herbert Y; Merikangas Kathleen R; Meyer-Lindenberg Andreas; Mirnics Károly; Monteggia Lisa M; Neumeister Alexander; O'Brien Charles P; Owen Michael J; Pine Daniel S; Rapoport Judith L; Rauch Scott L; Robbins Trevor W; Rosenbaum Jerrold F; Rosenberg David R; Ross Christopher A; Rush A John; Sackeim Harold A; Sanacora Gerard; Schatzberg Alan F; Shaham Yavin; Siever Larry J; Sunderland Trey; Tecott Laurence H; Thase Michael E; Todd Richard D; Weissman Myrna M; Yehuda Rachel; Yoshikawa Takeo; Young Elizabeth A; McCandless R
It is time to take a stand for medical research and against terrorism targeting medical scientists.
Biological psychiatry 2008;63(8):725-7.
2008: Meltzer Herbert Y; Bobo William V; Roy Ajanta; Jayathilake Karu; Chen Yuejin; Ertugrul Aygun; Anil Yagcioglu A Elif; Small Joyce G
A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.
The Journal of clinical psychiatry 2008;69(2):274-85.
2008: Meltzer Herbert Y; Huang Mei
In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
Progress in brain research 2008;172():177-97.
2007: Renou J; De Luca V; Zai C C; Bulgin N; Remington G; Meltzer H Y; Lieberman J A; Le Foll B; Kennedy J L
Multiple variants of the DRD3, but not BDNF gene, influence age-at-onset of schizophrenia.
Molecular psychiatry 2007;12(12):1058-60.
2007: Prus Adam J; Huang Mei; Li Zhu; Dai Jin; Meltzer Herbert Y
The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux.
Brain research 2007;1184():354-64.
2007: Ford Tamsin; Collishaw Stephan; Meltzer Howard; Goodman Robert
A prospective study of childhood psychopathology: independent predictors of change over three years.
Social psychiatry and psychiatric epidemiology 2007;42(12):953-61.
2007: Kang Hyo Jung; Adams David H; Simen Arthur; Simen Birgitte B; Rajkowska Grazyna; Stockmeier Craig A; Overholser James C; Meltzer Herbert Y; Jurjus George J; Konick Lisa C; Newton Samuel S; Duman Ronald S
Gene expression profiling in postmortem prefrontal cortex of major depressive disorder.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(48):13329-40.
2007: Elkis Helio; Meltzer Herbert Y
[Refractory schizophrenia]
Revista brasileira de psiquiatria (São Paulo, Brazil : 1999) 2007;29 Suppl 2():S41-7.
2007: De Luca Vincenzo; Müller Daniel J; Hwang Rudi; Lieberman Jeffrey A; Volavka Jan; Meltzer Herbert Y; Kennedy James L
HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis.
Human psychopharmacology 2007;22(7):463-7.
2007: Li Zhu; Bonhaus Douglas W; Huang Mei; Prus Adam J; Dai Jin; Meltzer Herbert Y
AC260584 (4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one), a selective muscarinic M1 receptor agonist, increases acetylcholine and dopamine release in rat medial prefrontal cortex and hippocampus.
European journal of pharmacology 2007;572(2-3):129-37.
2007: Zai Clement C; Hwang Rudi W; De Luca Vincenzo; Müller Daniel J; King Nicole; Zai Gwyneth C; Remington Gary; Meltzer Herbert Y; Lieberman Jeffrey A; Potkin Steven G; Kennedy James L
Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10(5):639-51.
2007: Altamura A Carlo; Bobo William V; Meltzer Herbert Y
Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment.
International clinical psychopharmacology 2007;22(5):249-67.
2007: Sumiyoshi Tomiki; Park Sohee; Jayathilake Karu; Roy Ajanta; Ertugrul Aygun; Meltzer Herbert Y
Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study.
Schizophrenia research 2007;95(1-3):158-68.
2007: Hwang Rudi; Shinkai Takahiro; De Luca Vincenzo; Ni Xingqun; Potkin Steven G; Lieberman Jeffrey A; Meltzer Herbert Y; Kennedy James L
Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response.
Journal of psychopharmacology (Oxford, England) 2007;21(7):718-27.
2007: Keefe Richard S E; Bilder Robert M; Davis Sonia M; Harvey Philip D; Palmer Barton W; Gold James M; Meltzer Herbert Y; Green Michael F; Capuano George; Stroup T Scott; McEvoy Joseph P; Swartz Marvin S; Rosenheck Robert A; Perkins Diana O; Davis Clarence E; Hsiao John K; Lieberman Jeffrey A;
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
Archives of general psychiatry 2007;64(6):633-47.
2007: Sumiyoshi Tomiki; Higuchi Yuko; Matsui Mie; Arai Hirofumi; Takamiya Chieko; Meltzer Herbert Y; Kurachi Masayoshi
Effective adjunctive use of tandospirone with perospirone for enhancing verbal memory and quality of life in schizophrenia.
Progress in neuro-psychopharmacology & biological psychiatry 2007;31(4):965-7.
2007: Meltzer Herbert Y
Illuminating the molecular basis for some antipsychotic drug-induced metabolic burden.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(9):3019-20.
2007: Kane John M; Meltzer Herbert Y; Carson William H; McQuade Robert D; Marcus Ronald N; Sanchez Raymond;
Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine.
The Journal of clinical psychiatry 2007;68(2):213-23.
2007: Li Zhu; Huang Mei; Prus Adam J; Dai Jin; Meltzer Herbert Y
5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
Brain research 2007;1134(1):70-8.
2007: Woodward Neil D; Jayathilake Karu; Meltzer Herbert Y
COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia.
Schizophrenia research 2007;90(1-3):86-96.
2007: Altamura A C; Mundo E; Bassetti R; Green A; Lindenmayer J P; Alphs L; Meltzer H Y
Transcultural differences in suicide attempters: analysis on a high-risk population of patients with schizophrenia or schizoaffective disorder.
Schizophrenia research 2007;89(1-3):140-6.
2007: Woodward Neil D; Purdon Scot E; Meltzer Herbert Y; Zald David H
A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects.
Schizophrenia research 2007;89(1-3):211-24.
2007: Marquis Karen L; Sabb Annmarie L; Logue Sheree F; Brennan Julie A; Piesla Michael J; Comery Tom A; Grauer Steven M; Ashby Charles R; Nguyen Huy Q; Dawson Lee A; Barrett James E; Stack Gary; Meltzer Herbert Y; Harrison Boyd L; Rosenzweig-Lipson Sharon
WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity.
The Journal of pharmacology and experimental therapeutics 2007;320(1):486-96.
2007: McCreary Andrew C; Glennon Jeffrey C; Ashby Charles R; Meltzer Herbert Y; Li Zhu; Reinders Jan-Hendrik; Hesselink Mayke B; Long Stephen K; Herremans Arnoud H; van Stuivenberg Herman; Feenstra Rolf W; Kruse Chris G
SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(1):78-94.
2007: Pompili Maurizio; Amador Xavier F; Girardi Paolo; Harkavy-Friedman Jill; Harrow Martin; Kaplan Kalman; Krausz Michael; Lester David; Meltzer Herbert Y; Modestin Jiri; Montross Lori P; Mortensen Preben Bo; Munk-Jørgensen Povl; Nielsen Jimmi; Nordentoft Merete; Saarinen Pirjo Irmeli; Zisook Sidney; Wilson Scott T; Tatarelli Roberto
Suicide risk in schizophrenia: learning from the past to change the future.
Annals of general psychiatry 2007;6():10.
2006: Akdede Berna Binnur Kivircik; Anil Yagcioglu A Elif; Alptekin Köksal; Turgut Tolga I; Tümüklü Mevhibe; Yazici M Kâzim; Jayathilake Karu; Tunca Zeliha; Gögüs Ahmet; Meltzer Herbert Y
A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
The Journal of clinical psychiatry 2006;67(12):1912-9.
2006: Sumiyoshi Chika; Sumiyoshi Tomiki; Roy Ajanta; Jayathilake Karu; Meltzer Herbert Y
Atypical antipsychotic drugs and organization of long-term semantic memory: multidimensional scaling and cluster analyses of category fluency performance in schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2006;9(6):677-83.
2006: Miguel-Hidalgo Jose J; Overholser James C; Meltzer Herbert Y; Stockmeier Craig A; Rajkowska Grazyna
Reduced glial and neuronal packing density in the orbitofrontal cortex in alcohol dependence and its relationship with suicide and duration of alcohol dependence.
Alcoholism, clinical and experimental research 2006;30(11):1845-55.
2006: Zai Gwyneth; Müller Daniel J; Volavka Jan; Czobor Pal; Lieberman Jeffrey A; Meltzer Herbert Y; Kennedy James L
Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication.
Psychopharmacology 2006;188(2):171-82.
2006: Basu Anirban; Meltzer Herbert Y
Differential trends in prevalence of diabetes and unrelated general medical illness for schizophrenia patients before and after the atypical antipsychotic era.
Schizophrenia research 2006;86(1-3):99-109.
2006: Kessler Robert M; Ansari M Sib; Riccardi Patrizia; Li Rui; Jayathilake Karuna; Dawant Benoit; Meltzer Herbert Y
Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(9):1991-2001.
2006: Keefe Richard S E; Bilder Robert M; Harvey Philip D; Davis Sonia M; Palmer Barton W; Gold James M; Meltzer Herbert Y; Green Michael F; Miller Del D; Canive Jose M; Adler Lawrence W; Manschreck Theo C; Swartz Marvin; Rosenheck Robert; Perkins Diana O; Walker Trina M; Stroup T Scott; McEvoy Joseph P; Lieberman Jeffrey A
Baseline neurocognitive deficits in the CATIE schizophrenia trial.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(9):2033-46.
2006: Basu Anirban; Meltzer Herbert Y; Dukic Vanja
Estimating transitions between symptom severity states over time in schizophrenia: a Bayesian meta-analytic approach.
Statistics in medicine 2006;25(17):2886-910.
2006: Huang Mei; Li Zhu; Ichikawa Junji; Dai Jin; Meltzer Herbert Y
Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex.
Brain research 2006;1099(1):44-55.
2006: Meltzer Herbert Y; Bobo William V
Interpreting the efficacy findings in the CATIE study: what clinicians should know.
CNS spectrums 2006;11(7 Suppl 7):14-24.
2006: Hwang Rudi; Shinkai Takahiro; Deluca Vincenzo; Macciardi Fabio; Potkin Steven; Meltzer Herbert Y; Kennedy James L
Dopamine D2 receptor gene variants and quantitative measures of positive and negative symptom response following clozapine treatment.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2006;16(4):248-59.
2006: Meltzer Herbert Y; Anil Yagcioglu A Elif; Akdede Berna Binnur Kivircik
Clozapine alone versus clozapine and risperidone for refractory schizophrenia.
The New England journal of medicine 2006;354(17):1846-8; author reply 1846-8.
2006: McEvoy Joseph P; Lieberman Jeffrey A; Stroup T Scott; Davis Sonia M; Meltzer Herbert Y; Rosenheck Robert A; Swartz Marvin S; Perkins Diana O; Keefe Richard S E; Davis Clarence E; Severe Joanne; Hsiao John K;
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.
The American journal of psychiatry 2006;163(4):600-10.
2006: Huang Mei; Ichiwaka Junji; Li Zhu; Dai Jin; Meltzer Herbert Y
Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex.
Psychopharmacology 2006;185(3):274-81.
2006: Mann J John; Emslie Graham; Baldessarini Ross J; Beardslee William; Fawcett Jan A; Goodwin Frederick K; Leon Andrew C; Meltzer Herbert Y; Ryan Neal D; Shaffer David; Wagner Karen D
ACNP Task Force report on SSRIs and suicidal behavior in youth.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(3):473-92.
2006: Shinkai Takahiro; Müller Daniel J; De Luca Vincenzo; Shaikh Sajid; Matsumoto Chima; Hwang Rudi; King Nicole; Trakalo Joseph; Potapova Natalia; Zai Gwyneth; Hori Hiroko; Ohmori Osamu; Meltzer Herbert Y; Nakamura Jun; Kennedy James L
Genetic association analysis of the glutathione peroxidase (GPX1) gene polymorphism (Pro197Leu) with tardive dyskinesia.
Psychiatry research 2006;141(2):123-8.
2005: Spooren Will; Riemer Claus; Meltzer Herbert
Opinion: NK3 receptor antagonists: the next generation of antipsychotics?
Nature reviews. Drug discovery 2005;4(12):967-75.
2005: Li Zhu; Ichikawa Junji; Huang Mei; Prus Adam J; Dai Jin; Meltzer Herbert Y
ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Psychopharmacology 2005;183(2):144-53.
2005: McEvoy Joseph P; Meyer Jonathan M; Goff Donald C; Nasrallah Henry A; Davis Sonia M; Sullivan Lisa; Meltzer Herbert Y; Hsiao John; Scott Stroup T; Lieberman Jeffrey A
Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.
Schizophrenia research 2005;80(1):19-32.
2005: Kessler Robert M; Ansari Mohammad Sib; Riccardi Patrizia; Li Rui; Jayathilake Karuna; Dawant Benoit; Meltzer Herbert Y
Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(12):2283-9.
2005: Shinkai Takahiro; De Luca Vincenzo; Hwang Rudi; Matsumoto Chima; Hori Hiroko; Ohmori Osamu; Remington Gary; Meltzer Herbert Y; Lieberman Jeffrey A; Potkin Steven G; Nakamura Jun; Kennedy James L
Association study between a functional glutathione S-transferase (GSTP1) gene polymorphism (Ile105Val) and tardive dyskinesia.
Neuroscience letters 2005;388(2):116-20.
2005: Li Zhu; Huang Mei; Ichikawa Junji; Dai Jin; Meltzer Herbert Y
N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(11):1986-95.
2005: Müller Daniel J; De Luca Vincenzo; Sicard Tricia; King Nicole; Hwang Rudi; Volavka Jan; Czobor Pal; Sheitman Brian B; Lindenmayer Jean-Pierre; Citrome Leslie; McEvoy Joseph P; Lieberman Jeffrey A; Meltzer Herbert Y; Kennedy James L
Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2005;15(5):525-31.
2005: Lerer Bernard; Segman Ronnen H; Tan Ene-Choo; Basile Vincenzo S; Cavallaro Roberto; Aschauer Harald N; Strous Rael; Chong Siow-Ann; Heresco-Levy Uriel; Verga Massimiliano; Scharfetter Joachim; Meltzer Herbert Y; Kennedy James L; Macciardi Fabio
Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(3):411-25.
2005: Sumiyoshi Tomiki; Jin Dai; Jayathilake Karu; Lee Myung; Meltzer Herbert Y
Prediction of the ability of clozapine to treat negative symptoms from plasma glycine and serine levels in schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(3):451-5.
2005: Woodward Neil D; Purdon Scot E; Meltzer Herbert Y; Zald David H
A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(3):457-72.
2005: Ichikawa Junji; Chung Young-Chul; Dai Jin; Meltzer Herbert Y
Valproic acid potentiates both typical and atypical antipsychotic-induced prefrontal cortical dopamine release.
Brain research 2005;1052(1):56-62.
2005: Hwang Rudi; Shinkai Takahiro; De Luca Vincenzo; Müller Daniel J; Ni Xingqun; Macciardi Fabio; Potkin Steven; Lieberman Jeffrey A; Meltzer Herbert Y; Kennedy James L
Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations.
Psychopharmacology 2005;181(1):179-87.
2005: Marston Cicely; Meltzer Howard; Majeed Azeem
Impact on contraceptive practice of making emergency hormonal contraception available over the counter in Great Britain: repeated cross sectional surveys.
BMJ (Clinical research ed.) 2005;331(7511):271.
2005: Ichikawa Junji; Dai Jin; Meltzer Herbert Y
Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: role of 5-HT(1A) receptor agonism.
Brain research 2005;1049(2):182-90.
2005: Crisp Arthur; Gelder Michael; Goddard Eileen; Meltzer Howard
Stigmatization of people with mental illnesses: a follow-up study within the Changing Minds campaign of the Royal College of Psychiatrists.
World psychiatry : official journal of the World Psychiatric Association (WPA) 2005;4(2):106-13.
2005: Meltzer Herbert Y
Focus on the metabolic consequences of long-term treatment with olanzapine, quetiapine and risperidone: are there differences?
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(2):153-6.
2005: Green Michael F; Barnes Thomas R; Danion Jean-Marie; Gallhofer Bernd; Meltzer Herbert Y; Pantelis Christos
The FOCIS international survey on psychiatrists' opinions on cognition in schizophrenia.
Schizophrenia research 2005;74(2-3):253-61.
2005: Meltzer Herbert Y
Suicide in schizophrenia, clozapine, and adoption of evidence-based medicine.
The Journal of clinical psychiatry 2005;66(4):530-3.
2005: Davies Marilyn A; Compton-Toth Beth Ann; Hufeisen Sandra J; Meltzer Herbert Y; Roth Bryan L
The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine's actions?
Psychopharmacology 2005;178(4):451-60.
2005: Anil Yagcioglu A Elif; Kivircik Akdede Berna B; Turgut Tolga I; Tümüklü Mevhibe; Yazici M Kâzim; Alptekin Köksal; Ertugrul Aygün; Jayathilake Karu; Gögüs Ahmet; Tunca Zeliha; Meltzer Herbert Y
A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety.
The Journal of clinical psychiatry 2005;66(1):63-72.
2004: Weiner D M; Meltzer H Y; Veinbergs I; Donohue E M; Spalding T A; Smith T T; Mohell N; Harvey S C; Lameh J; Nash N; Vanover K E; Olsson R; Jayathilake K; Lee M; Levey A I; Hacksell U; Burstein E S; Davis R E; Brann M R
The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine.
Psychopharmacology 2004;177(1-2):207-16.
2004: Sumiyoshi Tomiki; Roy A; Kim C-H; Jayathilake K; Lee M A; Sumiyoshi C; Meltzer H Y
Prediction of changes in memory performance by plasma homovanillic acid levels in clozapine-treated patients with schizophrenia.
Psychopharmacology 2004;177(1-2):79-83.
2004: Stockmeier Craig A; Mahajan Gouri J; Konick Lisa C; Overholser James C; Jurjus George J; Meltzer Herbert Y; Uylings Harry B M; Friedman Lee; Rajkowska Grazyna
Cellular changes in the postmortem hippocampus in major depression.
Biological psychiatry 2004;56(9):640-50.
2004: Meltzer Herbert Y
Cognitive factors in schizophrenia: causes, impact, and treatment.
CNS spectrums 2004;9(10 Suppl 11):15-24.
2004: Chung Young-Chul; Li Zhu; Dai Jin; Meltzer Herbert Y; Ichikawa Junji
Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism.
Brain research 2004;1023(1):54-63.
2004: McGurk Susan R; Mueser Kim T; Walling David; Harvey Philip D; Meltzer Herbert Y
Cognitive functioning predicts outpatient service utilization in schizophrenia.
Mental health services research 2004;6(3):185-8.
2004: Ertugrul Aygun; Kennedy James L; Masellis Mario; Basile Vincenzo S; Jayathilake Karuna; Meltzer Herbert Y
No association of the T102C polymorphism of the serotonin 2A receptor gene (HTR2A) with suicidality in schizophrenia.
Schizophrenia research 2004;69(2-3):301-5.
2004: Sumiyoshi Tomiki; Meltzer Herbert Y
Serotonin 1A receptors in memory function.
The American journal of psychiatry 2004;161(8):1505; author reply 1505-6.
2004: Bourgeois Marc; Swendsen Joel; Young Frederick; Amador Xavier; Pini Stefano; Cassano Giovanni B; Lindenmayer Jean-Pierre; Hsu Chuanchieh; Alphs Larry; Meltzer Herbert Y;
Awareness of disorder and suicide risk in the treatment of schizophrenia: results of the international suicide prevention trial.
The American journal of psychiatry 2004;161(8):1494-6.
2004: Sumiyoshi Tomiki; Roy Ajanta; Jayathilake Karu; Meltzer Herbert Y
The effect of hypertension and obesity on the development of diabetes mellitus in patients treated with atypical antipsychotic drugs.
Journal of clinical psychopharmacology 2004;24(4):452-4.
2004: Li Zhu; Ichikawa Junji; Dai Jin; Meltzer Herbert Y
Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
European journal of pharmacology 2004;493(1-3):75-83.
2004: Meltzer Herbert Y; Arvanitis Lisa; Bauer Deborah; Rein Werner;
Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder.
The American journal of psychiatry 2004;161(6):975-84.
2004: Sumiyoshi Tomiki; Roy Ajanta; Anil A Elif; Jayathilake Karu; Ertugrul Aygun; Meltzer Herbert Y
A comparison of incidence of diabetes mellitus between atypical antipsychotic drugs: a survey for clozapine, risperidone, olanzapine, and quetiapine.
Journal of clinical psychopharmacology 2004;24(3):345-8.
2004: Jaskiw George E; Hussain Ghazala; Stephans Stacy E; Yamamoto Bryan K; Meltzer Herbert Y
Clozapine prolongs hypotonic immobility in rats with bilateral 6-hydroxydopamine lesions of the striatum.
Neuroscience letters 2004;362(1):35-8.
2004: Sumiyoshi Tomiki; Anil A Elif; Jin Dai; Jayathilake Karu; Lee Myung; Meltzer Herbert Y
Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2004;7(1):1-8.
2004: Harvey Philip D; Meltzer Herbert; Simpson George M; Potkin Steven G; Loebel Antony; Siu Cynthia; Romano Steven J
Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia.
Schizophrenia research 2004;66(2-3):101-13.
2004: Meltzer Herbert Y
What's atypical about atypical antipsychotic drugs?
Current opinion in pharmacology 2004;4(1):53-7.
2004: Prus Adam J; Baker Lisa E; Meltzer Herbert Y
Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms.
Pharmacology, biochemistry, and behavior 2004;77(2):199-208.
2004: Alphs Larry; Anand Ravi; Islam M Zahur; Meltzer Herbert Y; Kane John M; Krishnan Ranga; Green Alan I; Potkin Steven; Chouinard Guy; Lindenmayer Jean-Pierre; Kerwin Rob
The international suicide prevention trial (interSePT): rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients.
Schizophrenia bulletin 2004;30(3):577-86.
2004: McGurk Susan R; Lee M A; Jayathilake K; Meltzer Herbert Y
Cognitive effects of olanzapine treatment in schizophrenia.
MedGenMed : Medscape general medicine 2004;6(2):27.
2003: Meltzer Herbert Y
Beyond control of acute exacerbation: enhancing affective and cognitive outcomes.
CNS spectrums 2003;8(11 Suppl 2):16-8, 22.
2003: Bonaccorso Stefania; Maier Steven F; Meltzer Herbert Y; Maes Michael
Behavioral changes in rats after acute, chronic and repeated administration of interleukin-1beta: relevance for affective disorders.
Journal of affective disorders 2003;77(2):143-8.
2003: Meltzer Herbert Y; Li Zhu; Kaneda Yasuhiro; Ichikawa Junji
Serotonin receptors: their key role in drugs to treat schizophrenia.
Progress in neuro-psychopharmacology & biological psychiatry 2003;27(7):1159-72.
2003: Meltzer Herbert Y; Baldessarini Ross J
Reducing the risk for suicide in schizophrenia and affective disorders.
The Journal of clinical psychiatry 2003;64(9):1122-9.
2003: Ertugrul Aygun; Meltzer Herbert Y
Antipsychotic drugs in bipolar disorder.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2003;6(3):277-84.
2003: Harvey Philip D; Green Michael F; McGurk Susan R; Meltzer Herbert Y
Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study.
Psychopharmacology 2003;169(3-4):404-11.
2003: Potkin Steven G; Alphs Larry; Hsu Chuanchieh; Krishnan K Ranga Rama; Anand Ravi; Young Frederick K; Meltzer Herbert; Green Alan;
Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial.
Biological psychiatry 2003;54(4):444-52.
2003: Weiner David M; Vanover Kimberly E; Brann Mark R; Meltzer Herbert Y; Davis Robert E
Psychosis of Parkinson's disease: serotonin 2A receptor inverse agonists as potential therapeutics.
Current opinion in investigational drugs (London, England : 2000) 2003;4(7):815-9.
2003: Jaskiw George E; Blumer Tim E; Gutierrez-Esteinou Rolando; Meltzer Herbert Y; Steele Vickie; Strauss Milton E
Comparison of inpatients with major mental illness who do and do not consent to low-risk research.
Psychiatry research 2003;119(1-2):183-8.
2003: Sumiyoshi Tomiki; Jayathilake Karu; Meltzer Herbert Y
A comparison of two doses of melperone, an atypical antipsychotic drug, in the treatment of schizophrenia.
Schizophrenia research 2003;62(1-2):65-72.
2003: Li Zhu; Kim Chan H; Ichikawa Junji; Meltzer Herbert Y
Effect of repeated administration of phencyclidine on spatial performance in an eight-arm radial maze with delay in rats and mice.
Pharmacology, biochemistry, and behavior 2003;75(2):335-40.
2003: Kuroki Toshihide; Meltzer Herbert Y; Ichikawa Junji
5-HT 2A receptor stimulation by DOI, a 5-HT 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Brain research 2003;972(1-2):216-21.
2003: Li Zhu; Ichikawa Junji; Meltzer Herbert Y
A comparison of the effects of loxapine with ziprasidone and thioridazine on the release of dopamine and acetylcholine in the prefrontal cortex and nucleus accumbens.
Psychopharmacology 2003;167(3):315-23.
2003: Kroeze Wesley K; Hufeisen Sandra J; Popadak Beth A; Renock Sean M; Steinberg SeAnna; Ernsberger Paul; Jayathilake Karu; Meltzer Herbert Y; Roth Bryan L
H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(3):519-26.
2003: Kim Chan-Hyung; Jayathilake Karu; Meltzer Herbert Y
Hopelessness, neurocognitive function, and insight in schizophrenia: relationship to suicidal behavior.
Schizophrenia research 2003;60(1):71-80.
2003: Meltzer Herbert Y; Sumiyoshi Tomiki
Atypical antipsychotic drugs improve cognition in schizophrenia.
Biological psychiatry 2003;53(3):265-7; author reply 267-8.
2003: Meltzer Herbert Y; Alphs Larry; Green Alan I; Altamura A Carlo; Anand Ravi; Bertoldi Alberto; Bourgeois Marc; Chouinard Guy; Islam M Zahur; Kane John; Krishnan Ranga; Lindenmayer J P; Potkin Steven;
Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).
Archives of general psychiatry 2003;60(1):82-91.
2003: Meltzer Herbert Y; Perry Edward; Jayathilake Karuna
Clozapine-induced weight gain predicts improvement in psychopathology.
Schizophrenia research 2003;59(1):19-27.
2003: Sumiyoshi Tomiki; Jayathilake Karu; Meltzer Herbert Y
The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophrenia.
Schizophrenia research 2003;59(1):7-16.
2003: Keefe Richard S E; Mohs Richard C; Bilder Robert M; Harvey Philip D; Green Michael F; Meltzer Herbert Y; Gold James M; Sano Mary
Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale.
Schizophrenia bulletin 2003;29(1):45-55.
2002: Ichikawa Junji; Chung Young Chul; Li Zhu; Dai Jin; Meltzer Herbert Y
Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Brain research 2002;958(1):176-84.
2002: Basile Vincenzo S; Masellis Mario; De Luca Vincenzo; Meltzer Herbert Y; Kennedy James L
759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain.
Lancet 2002;360(9347):1790-1.
2002: Ichikawa Junji; Li Zhu; Dai Jin; Meltzer Herbert Y
Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
Brain research 2002;956(2):349-57.
2002: Rajkowska Grazyna; Miguel-Hidalgo Jose Javier; Makkos Zoltan; Meltzer Herbert; Overholser James; Stockmeier Craig
Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia.
Schizophrenia research 2002;57(2-3):127-38.
2002: Bonaccorso Stefania; Meltzer Herbert Y; Li Zhu; Dai Jin; Alboszta Anna R; Ichikawa Junji
SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;27(3):430-41.
2002: Arato M; O'Connor R; Meltzer H Y;
A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study.
International clinical psychopharmacology 2002;17(5):207-15.
2002: Singleton Nicola; Meltzer Howard
Mental disorders in prisoners.
Lancet 2002;360(9332):572-3; author reply 573.
2002: Meltzer Herbert Y
Commentary on "clinical studies on the mechanism of action of clozapine; the dopamine-serotonin hypothesis of schizophrenia." Psychopharmacology (1989) 99:S18-S27.
Psychopharmacology 2002;163(1):1-3.
2002: Liégeois Jean-François; Ichikawa Junji; Meltzer Herbert Y
5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner.
Brain research 2002;947(2):157-65.
2002: Meltzer Herbert Y
Suicidality in schizophrenia: a review of the evidence for risk factors and treatment options.
Current psychiatry reports 2002;4(4):279-83.
2002: Stockmeier Craig A; Shi Xiaochun; Konick Lisa; Overholser James C; Jurjus George; Meltzer Herbert Y; Friedman Lee; Blier Pierre; Rajkowska Grazyna
Neurokinin-1 receptors are decreased in major depressive disorder.
Neuroreport 2002;13(9):1223-7.
2002: Lerer Bernard; Segman Ronnen H; Fangerau Heiner; Daly Ann K; Basile Vincenzo S; Cavallaro Roberto; Aschauer Harald N; McCreadie Robin G; Ohlraun Stephanie; Ferrier Nicol; Masellis Mario; Verga Massimiliano; Scharfetter Joachim; Rietschel Marcella; Lovlie Roger; Levy Uriel Heresco; Meltzer Herbert Y; Kennedy James L; Steen Vidar M; Macciardi Fabio
Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;27(1):105-19.
2002: Kessler Robert M; Meltzer Herbert Y
Regional selectivity in clozapine treatment?
The American journal of psychiatry 2002;159(6):1064-5.
2002: Ichikawa Junji; Dai Jin; Meltzer Herbert Y
5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.
Brain research 2002;939(1-2):34-42.
2002: Ichikawa Junji; Dai Jin; O'Laughlin Ian A; Fowler Wiley L; Meltzer Herbert Y
Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;26(3):325-39.
2002: Meltzer Herbert
Clozapine and suicide.
The American journal of psychiatry 2002;159(2):323-4.
2002: Bonaccorso Stefania; Marino Valentina; Puzella Antonella; Pasquini Massimo; Biondi Massimo; Artini Marco; Almerighi Cristiana; Verkerk Robert; Meltzer Herbert; Maes Michael
Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system.
Journal of clinical psychopharmacology 2002;22(1):86-90.
2002: Meltzer Herbert Y
Action of atypical antipsychotics.
The American journal of psychiatry 2002;159(1):153-4; author reply 154-5.
2002: Meltzer Herbert Y; Davidson Michael; Glassman Alexander H; Vieweg W Victor R
Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment.
The Journal of clinical psychiatry 2002;63 Suppl 9():25-9.
2001: Meltzer H Y; Sumiyoshi T; Jayathilake K
Melperone in the treatment of neuroleptic-resistant schizophrenia.
Psychiatry research 2001;105(3):201-9.
2001: Bonaccorso S; Puzella A; Marino V; Pasquini M; Biondi M; Artini M; Almerighi C; Levrero M; Egyed B; Bosmans E; Meltzer H Y; Maes M
Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms.
Psychiatry research 2001;105(1-2):45-55.
2001: Lee M A; Meltzer H Y
5-HT(1A) receptor dysfunction in female patients with schizophrenia.
Biological psychiatry 2001;50(10):758-66.
2001: Sumiyoshi T; Matsui M; Nohara S; Yamashita I; Kurachi M; Sumiyoshi C; Jayathilake K; Meltzer H Y
Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment.
The American journal of psychiatry 2001;158(10):1722-5.
2001: Rauser L; Savage J E; Meltzer H Y; Roth B L
Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor.
The Journal of pharmacology and experimental therapeutics 2001;299(1):83-9.
2001: Lee J H; Woo J I; Meltzer H Y
Effects of clozapine on sleep measures and sleep-associated changes in growth hormone and cortisol in patients with schizophrenia.
Psychiatry research 2001;103(2-3):157-66.
2001: Klimek V; Zhu M Y; Dilley G; Konick L; Overholser J C; Meltzer H Y; May W L; Stockmeier C A; Ordway G A
Effects of long-term cigarette smoking on the human locus coeruleus.
Archives of general psychiatry 2001;58(9):821-7.
2001: Maes M; Bonaccorso S; Marino V; Puzella A; Pasquini M; Biondi M; Artini M; Almerighi C; Meltzer H
Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation.
Molecular psychiatry 2001;6(4):475-80.
2001: Ichikawa J; Dai J; Meltzer H Y
DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release.
Brain research 2001;907(1-2):151-5.
2001: Sumiyoshi T; Matsui M; Yamashita I; Nohara S; Kurachi M; Uehara T; Sumiyoshi S; Sumiyoshi C; Meltzer H Y
The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia.
Biological psychiatry 2001;49(10):861-8.
2001: Niswender C M; Herrick-Davis K; Dilley G E; Meltzer H Y; Overholser J C; Stockmeier C A; Emeson R B; Sanders-Bush E
RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;24(5):478-91.
2001: Meltzer H Y
Treatment of suicidality in schizophrenia.
Annals of the New York Academy of Sciences 2001;932():44-58; discussion 58-60.
2001: Basile V S; Ozdemir V; Masellis M; Meltzer H Y; Lieberman J A; Potkin S G; Macciardi F M; Petronis A; Kennedy J L
Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia.
Molecular psychiatry 2001;6(2):230-4.
2001: Ichikawa J; Ishii H; Bonaccorso S; Fowler W L; O'Laughlin I A; Meltzer H Y
5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.
Journal of neurochemistry 2001;76(5):1521-31.
2001: Meltzer H Y; Lee M A; Jayathilake K
The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;24(3):278-90.
2001: Masellis M; Basile V S; Meltzer H Y; Lieberman J A; Sevy S; Goldman D A; Hamblin M W; Macciardi F M; Kennedy J L
Lack of association between the T-->C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia.
Schizophrenia research 2001;47(1):49-58.
2001: Shelton R C; Tollefson G D; Tohen M; Stahl S; Gannon K S; Jacobs T G; Buras W R; Bymaster F P; Zhang W; Spencer K A; Feldman P D; Meltzer H Y
A novel augmentation strategy for treating resistant major depression.
The American journal of psychiatry 2001;158(1):131-4.
2001: Meltzer H Y
Putting metabolic side effects into perspective: risks versus benefits of atypical antipsychotics.
The Journal of clinical psychiatry 2001;62 Suppl 27():35-9; discussion 40-1.
2001: Basile V S; Masellis M; McIntyre R S; Meltzer H Y; Lieberman J A; Kennedy J L
Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
The Journal of clinical psychiatry 2001;62 Suppl 23():45-66.
2000: Miguel-Hidalgo J J; Baucom C; Dilley G; Overholser J C; Meltzer H Y; Stockmeier C A; Rajkowska G
Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder.
Biological psychiatry 2000;48(8):861-73.
2000: McGurk S R; Meltzer H Y
The role of cognition in vocational functioning in schizophrenia.
Schizophrenia research 2000;45(3):175-84.
2000: Kuroki T; Dai J; Meltzer H Y; Ichikawa J
R(+)-8-OH-DPAT, a selective 5-HT(1A) receptor agonist, attenuated amphetamine-induced dopamine synthesis in rat striatum, but not nucleus accumbens or medial prefrontal cortex.
Brain research 2000;872(1-2):204-7.
2000: Basile V S; Ozdemir V; Masellis M; Walker M L; Meltzer H Y; Lieberman J A; Potkin S G; Alva G; Kalow W; Macciardi F M; Kennedy J L
A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia.
Molecular psychiatry 2000;5(4):410-7.
2000: Meltzer H Y
Massive serum creatine kinase increases with atypical antipsychotic drugs: what is the mechanism and the message?
Psychopharmacology 2000;150(3):349-50.
2000: Sumiyoshi T; Matsui M; Yamashita I; Nohara S; Uehara T; Kurachi M; Meltzer H Y
Effect of adjunctive treatment with serotonin-1A agonist tandospirone on memory functions in schizophrenia.
Journal of clinical psychopharmacology 2000;20(3):386-8.
2000: Vincent J B; Neves-Pereira M L; Paterson A D; Yamamoto E; Parikh S V; Macciardi F; Gurling H M; Potkin S G; Pato C N; Macedo A; Kovacs M; Davies M; Lieberman J A; Meltzer H Y; Petronis A; Kennedy J L
An unstable trinucleotide-repeat region on chromosome 13 implicated in spinocerebellar ataxia: a common expansion locus.
American journal of human genetics 2000;66(3):819-29.
2000: Ichikawa J; Meltzer H Y
The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
Brain research 2000;858(2):252-63.
2000: Masellis M; Basile V S; Ozdemir V; Meltzer H Y; Macciardi F M; Kennedy J L
Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine.
Biological psychiatry 2000;47(3):252-66.
2000: Meltzer H Y
Genetics and etiology of schizophrenia and bipolar disorder.
Biological psychiatry 2000;47(3):171-3.
2000: Park S; Knopick C; McGurk S; Meltzer H Y
Nicotine impairs spatial working memory while leaving spatial attention intact.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;22(2):200-9.
2000: Meltzer H Y
An atypical compound by any other name is still a.
Psychopharmacology 2000;148(1):16-9.
2000: Conley R R; Meltzer H Y
Adverse events related to olanzapine.
The Journal of clinical psychiatry 2000;61 Suppl 8():26-9; discussion 30.
1999: Ichikawa J; Meltzer H Y
R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
The Journal of pharmacology and experimental therapeutics 1999;291(3):1227-32.
1999: Meltzer H Y
Treatment of schizophrenia and spectrum disorders: pharmacotherapy, psychosocial treatments, and neurotransmitter interactions.
Biological psychiatry 1999;46(10):1321-7.
1999: Meltzer H Y; Park S; Kessler R
Cognition, schizophrenia, and the atypical antipsychotic drugs.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(24):13591-3.
1999: Ordway G A; Farley J T; Dilley G E; Overholser J C; Meltzer H Y; Balraj E K; Stockmeier C A; Klimek V
Quantitative distribution of monoamine oxidase A in brainstem monoamine nuclei is normal in major depression.
Brain research 1999;847(1):71-9.
1999: Zhu M Y; Klimek V; Dilley G E; Haycock J W; Stockmeier C; Overholser J C; Meltzer H Y; Ordway G A
Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression.
Biological psychiatry 1999;46(9):1275-86.
1999: Ichikawa J; Meltzer H Y
The effect of ipsapirone and S(-)-pindolol on dopamine release in rat striatum and nucleus accumbens.
Brain research 1999;842(2):445-51.
1999: Ichikawa J; Meltzer H Y
Valproate and carbamazepine increase prefrontal dopamine release by 5-HT1A receptor activation.
European journal of pharmacology 1999;380(1):R1-3.
1999: Meltzer H Y
The role of serotonin in antipsychotic drug action.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;21(2 Suppl):106S-115S.
1999: Meltzer H Y
Risperidone and clozapine for treatment-resistant schizophrenia.
The American journal of psychiatry 1999;156(7):1126-7; author reply 1127-8.
1999: Meltzer H Y
Dopamine2 receptor occupancy and the action of clozapine: does it make a difference to add a neuroleptic?
Biological psychiatry 1999;46(1):144-9.
1999: Klimek V; Rajkowska G; Luker S N; Dilley G; Meltzer H Y; Overholser J C; Stockmeier C A; Ordway G A
Brain noradrenergic receptors in major depression and schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;21(1):69-81.
1999: Basile V S; Masellis M; Badri F; Paterson A D; Meltzer H Y; Lieberman J A; Potkin S G; Macciardi F; Kennedy J L
Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;21(1):17-27.
1999: Young C D; Bubser M; Meltzer H Y; Deutch A Y
Clozapine pretreatment modifies haloperidol-elicited forebrain Fos induction: a regionally-specific double dissociation.
Psychopharmacology 1999;144(3):255-63.
1999: Vincent J B; Petronis A; Strong E; Parikh S V; Meltzer H Y; Lieberman J; Kennedy J L
Analysis of genome-wide CAG/CTG repeats, and at SEF2-1B and ERDA1 in schizophrenia and bipolar affective disorder.
Molecular psychiatry 1999;4(3):229-34.
1999: Rietschel M; Kennedy J L; Macciardi F; Meltzer H Y
Application of pharmacogenetics to psychotic disorders: the first consensus conference. The Consensus Group for Outcome Measures in Psychoses for Pharmacological Studies.
Schizophrenia research 1999;37(2):191-6.
1999: Rajkowska G; Miguel-Hidalgo J J; Wei J; Dilley G; Pittman S D; Meltzer H Y; Overholser J C; Roth B L; Stockmeier C A
Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression.
Biological psychiatry 1999;45(9):1085-98.
1999: Lee M A; Jayathilake K; Meltzer H Y
A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia.
Schizophrenia research 1999;37(1):1-11.
1999: Maes M; Libbrecht I; van Hunsel F; Campens D; Meltzer H Y
Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance.
Journal of clinical psychopharmacology 1999;19(2):177-82.
1999: Maes M; Christophe A; Delanghe J; Altamura C; Neels H; Meltzer H Y
Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients.
Psychiatry research 1999;85(3):275-91.
1999: Truffinet P; Tamminga C A; Fabre L F; Meltzer H Y; Rivière M E; Papillon-Downey C
Placebo-controlled study of the D4/5-HT2A antagonist fananserin in the treatment of schizophrenia.
The American journal of psychiatry 1999;156(3):419-25.
1999: Meyers B S; Alexopoulos G S; Kakuma T; Tirumalasetti F; Gabriele M; Alpert S; Bowden C; Meltzer H Y
Decreased dopamine beta-hydroxylase activity in unipolar geriatric delusional depression.
Biological psychiatry 1999;45(4):448-52.
1999: Maes M; Van Gastel A; Delmeire L; Meltzer H Y
Decreased platelet alpha-2 adrenoceptor density in major depression: effects of tricyclic antidepressants and fluoxetine.
Biological psychiatry 1999;45(3):278-84.
1999: Kuroki T; Meltzer H Y; Ichikawa J
Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens.
The Journal of pharmacology and experimental therapeutics 1999;288(2):774-81.
1999: Ichikawa J; Meltzer H Y
Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs.
European archives of psychiatry and clinical neuroscience 1999;249 Suppl 4():90-8.
1999: Meltzer H Y; McGurk S R
The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.
Schizophrenia bulletin 1999;25(2):233-55.
1999: Meltzer H Y
Suicide and schizophrenia: clozapine and the InterSePT study. International Clozaril/Leponex Suicide Prevention Trial.
The Journal of clinical psychiatry 1999;60 Suppl 12():47-50.
1999: Meltzer H Y; Jayathilake K
Low-dose loxapine in the treatment of schizophrenia: is it more effective and more "atypical" than standard-dose loxapine?
The Journal of clinical psychiatry 1999;60 Suppl 10():47-51.
1999: Meltzer H Y
Outcome in schizophrenia: beyond symptom reduction.
The Journal of clinical psychiatry 1999;60 Suppl 3():3-7; discussion 8.
1998: Masellis M; Basile V; Meltzer H Y; Lieberman J A; Sevy S; Macciardi F M; Cola P; Howard A; Badri F; Nöthen M M; Kalow W; Kennedy J L
Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1998;19(2):123-32.
1998: Fatemi S H; Sidwell R; Kist D; Akhter P; Meltzer H Y; Bailey K; Thuras P; Sedgwick J
Differential expression of synaptosome-associated protein 25 kDa [SNAP-25] in hippocampi of neonatal mice following exposure to human influenza virus in utero.
Brain research 1998;800(1):1-9.
1998: Young C D; Meltzer H Y; Deutch A Y
Effects of desmethylclozapine on Fos protein expression in the forebrain: in vivo biological activity of the clozapine metabolite.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1998;19(1):99-103.
1998: Ichikawa J; Kuroki T; Meltzer H Y
Differential effects of chronic imipramine and fluoxetine on basal and amphetamine-induced extracellular dopamine levels in rat nucleus accumbens.
European journal of pharmacology 1998;350(2-3):159-64.
1998: Hong W W; Rak I W; Ciuryla V T; Wilson A M; Kylstra J W; Meltzer H Y; Carpenter W T; Lehman A; Arvanitis L A
Medical-claims databases in the design of a health-outcomes comparison of quetiapine ('Seroquel') and usual-care antipsychotic medication.
Schizophrenia research 1998;32(1):51-8.
1998: Ichikawa J; Kuroki T; Dai J; Meltzer H Y
Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
European journal of pharmacology 1998;351(2):163-71.
1998: Summerfelt W T; Meltzer H Y
Efficacy vs. effectiveness in psychiatric research.
Psychiatric services (Washington, D.C.) 1998;49(6):834-5.
1998: Meltzer H Y; Lee M; Cola P
The evolution of treatment resistance: biologic implications.
Journal of clinical psychopharmacology 1998;18(2 Suppl 1):5S-11S.
1998: Meltzer H Y; Pringuey D
Treatment-resistant schizophrenia: the importance of early detection and treatment. Introduction.
Journal of clinical psychopharmacology 1998;18(2 Suppl 1):1S.
1998: Jope R S; Song L; Grimes C A; Pacheco M A; Dilley G E; Li X; Meltzer H Y; Overholser J C; Stockmeier C A
Selective increases in phosphoinositide signaling activity and G protein levels in postmortem brain from subjects with schizophrenia or alcohol dependence.
Journal of neurochemistry 1998;70(2):763-71.
1998: Willins D L; Meltzer H Y
Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens.
Brain research 1998;781(1-2):291-9.
1998: Meltzer H Y
Suicide in schizophrenia: risk factors and clozapine treatment.
The Journal of clinical psychiatry 1998;59 Suppl 3():15-20.
1998: Roth B L; Meltzer H Y; Khan N
Binding of typical and atypical antipsychotic drugs to multiple neurotransmitter receptors.
Advances in pharmacology (San Diego, Calif.) 1998;42():482-5.
1997: Klimek V; Stockmeier C; Overholser J; Meltzer H Y; Kalka S; Dilley G; Ordway G A
Reduced levels of norepinephrine transporters in the locus coeruleus in major depression.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1997;17(21):8451-8.
1997: Maes M; Westenberg H; Vandoolaeghe E; Demedts P; Wauters A; Neels H; Meltzer H Y
Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine.
Journal of clinical psychopharmacology 1997;17(5):358-64.
1997: Maes M; Vandoolaeghe E; Neels H; Demedts P; Wauters A; Meltzer H Y; Altamura C; Desnyder R
Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness.
Biological psychiatry 1997;42(5):349-58.
1997: Maes M; Bosmans E; Kenis G; De Jong R; Smith R S; Meltzer H Y
In vivo immunomodulatory effects of clozapine in schizophrenia.
Schizophrenia research 1997;26(2-3):221-5.
1997: Meltzer H Y
Clozapine withdrawal: serotonergic or dopaminergic mechanisms?
Archives of general psychiatry 1997;54(8):760-3.
1997: Willins D L; Meltzer H Y
Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.
The Journal of pharmacology and experimental therapeutics 1997;282(2):699-706.
1997: Maes M; Calabrese J; Jayathilake K; Meltzer H Y
Effects of subchronic treatment with valproate on L-5-HTP-induced cortisol responses in mania: evidence for increased central serotonergic neurotransmission.
Psychiatry research 1997;71(2):67-76.
1997: Abraham J T; Brown R; Meltzer H Y
Clozapine treatment of persistent paroxysmal dyskinesia associated with concomitant paroxetine and sumatriptan use.
Biological psychiatry 1997;42(2):144-6.
1997: Meltzer H; Bastani B; Jayathilake K; Maes M
Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;17(1):1-11.
1997: Sumiyoshi T; Ichikawa J; Meltzer H Y
Increased S(-)-apomorphine-induced vacuous chewing and attenuated effect of chronic haloperidol treatment in streptozotocin-induced diabetic rat.
Pharmacology, biochemistry, and behavior 1997;57(1-2):19-22.
1997: Parsa M A; Szigethy E; Voci J M; Meltzer H Y
Risperidone in treatment of choreoathetosis of Huntington's disease.
Journal of clinical psychopharmacology 1997;17(2):134-5.
1997: Al-Semaan Y M; Clay H A; Meltzer H Y
Clozapine in treatment of bromocriptine-induced psychosis.
Journal of clinical psychopharmacology 1997;17(2):126-8.
1997: Meltzer H Y; Rabinowitz J; Lee M A; Cola P A; Ranjan R; Findling R L; Thompson P A
Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance.
The American journal of psychiatry 1997;154(4):475-82.
1997: Buckley P F; Friedman L; Wu D; Lai S; Meltzer H Y; Haacke E M; Miller D; Lewin J S
Functional magnetic resonance imaging in schizophrenia: initial methodology and evaluation of the motor cortex.
Psychiatry research 1997;74(1):13-23.
1997: Sumiyoshi T; Ichikawa J; Meltzer H Y
The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;16(3):183-90.
1997: Maes M; Smith R; Christophe A; Vandoolaeghe E; Van Gastel A; Neels H; Demedts P; Wauters A; Meltzer H Y
Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers.
Acta psychiatrica Scandinavica 1997;95(3):212-21.
1997: Sumiyoshi T; Hasegawa M; Jayathilake K; Meltzer H Y
Prediction of short-term changes in symptom severity by baseline plasma homovanillic acid levels in schizophrenic patients receiving clozapine.
Psychiatry research 1997;69(2-3):113-21.
1997: Sumiyoshi T; Hasegawa M; Jayathilake K; Meltzer H Y
Sex differences in plasma homovanillic acid levels in schizophrenia and normal controls: relation to neuroleptic resistance.
Biological psychiatry 1997;41(5):560-6.
1997: Stockmeier C A; Dilley G E; Shapiro L A; Overholser J C; Thompson P A; Meltzer H Y
Serotonin receptors in suicide victims with major depression.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;16(2):162-73.
1997: Stuve T A; Friedman L; Jesberger J A; Gilmore G C; Strauss M E; Meltzer H Y
The relationship between smooth pursuit performance, motion perception and sustained visual attention in patients with schizophrenia and normal controls.
Psychological medicine 1997;27(1):143-52.
1997: Maes M; Delange J; Ranjan R; Meltzer H Y; Desnyder R; Cooremans W; Scharpé S
Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs.
Psychiatry research 1997;66(1):1-11.
1997: Meltzer H Y
Treatment-resistant schizophrenia--the role of clozapine.
Current medical research and opinion 1997;14(1):1-20.
1996: Kuroki T; Ichikawa J; Dai J; Meltzer H Y
R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex.
Brain research 1996;743(1-2):357-61.
1996: Maes M; Meltzer H Y
Effects of meta-chlorophenylpiperazine on neuroendocrine and behavioral responses in male schizophrenic patients and normal volunteers.
Psychiatry research 1996;64(3):147-59.
1996: Meltzer H Y; Cola P A; Parsa M
Marked elevations of serum creatine kinase activity associated with antipsychotic drug treatment.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;15(4):395-405.
1996: Maes M; Van Gastel A; Ranjan R; Blockx P; Cosyns P; Meltzer H Y; Desnyder R
Stimulatory effects of L-5-hydroxytryptophan on postdexamethasone beta-endorphin levels in major depression.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;15(4):340-8.
1996: Findling R L; Jayathilake K; Meltzer H Y
Pre-morbid asociality in neuroleptic-resistant and neuroleptic-responsive schizophrenia.
Psychological medicine 1996;26(5):1033-41.
1996: Lewin J S; Friedman L; Wu D; Miller D A; Thompson L A; Klein S K; Wise A L; Hedera P; Buckley P; Meltzer H; Friedland R P; Duerk J L
Cortical localization of human sustained attention: detection with functional MR using a visual vigilance paradigm.
Journal of computer assisted tomography 1996;20(5):695-701.
1996: Hudson C J; Kennedy J L; Gotowiec A; Lin A; King N; Gojtan K; Macciardi F; Skorecki K; Meltzer H Y; Warsh J J; Horrobin D F
Genetic variant near cytosolic phospholipase A2 associated with schizophrenia.
Schizophrenia research 1996;21(2):111-6.
1996: Ranjan R; Meltzer H Y
Acute and long-term effectiveness of clozapine in treatment-resistant psychotic depression.
Biological psychiatry 1996;40(4):253-8.
1996: Maes M; Bosmans E; Ranjan R; Vandoolaeghe E; Meltzer H Y; De Ley M; Berghmans R; Stans G; Desnyder R
Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs.
Schizophrenia research 1996;21(1):39-50.
1996: Goyer P F; Berridge M S; Morris E D; Semple W E; Compton-Toth B A; Schulz S C; Wong D F; Miraldi F; Meltzer H Y
PET measurement of neuroreceptor occupancy by typical and atypical neuroleptics.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(7):1122-7.
1996: Elkis H; Friedman L; Buckley P F; Lee H S; Lys C; Kaufman B; Meltzer H Y
Increased prefrontal sulcal prominence in relatively young patients with unipolar major depression.
Psychiatry research 1996;67(2):123-34.
1996: Sasaki T; Macciardi F M; Badri F; Verga M; Meltzer H Y; Lieberman J; Howard A; Bean G; Joffe R T; Hudson C J; Kennedy J L
No evidence for association of dopamine D2 receptor variant (Ser311/Cys311) with major psychosis.
American journal of medical genetics 1996;67(4):415-7.
1996: Pacheco M A; Stockmeier C; Meltzer H Y; Overholser J C; Dilley G E; Jope R S
Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain.
Brain research 1996;723(1-2):37-45.
1996: Calabrese J R; Kimmel S E; Woyshville M J; Rapport D J; Faust C J; Thompson P A; Meltzer H Y
Clozapine for treatment-refractory mania.
The American journal of psychiatry 1996;153(6):759-64.
1996: Vincent J B; Klempan T; Parikh S S; Sasaki T; Meltzer H Y; Sirugo G; Cola P; Petronis A; Kennedy J L
Frequency analysis of large CAG/CTG trinucleotide repeats in schizophrenia and bipolar affective disorder.
Molecular psychiatry 1996;1(2):141-8.
1996: Meltzer H Y
Pre-clinical pharmacology of atypical antipsychotic drugs: a selective review.
The British journal of psychiatry. Supplement 1996;(29):23-31.
1996: Maes M; Smith R; Christophe A; Cosyns P; Desnyder R; Meltzer H
Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids.
Journal of affective disorders 1996;38(1):35-46.
1996: Meltzer H Y; Lee M A; Ranjan R; Mason E A; Cola P A
Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine.
Psychopharmacology 1996;124(1-2):176-87.
1996: Meltzer H Y; Thompson P A; Lee M A; Ranjan R
Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;14(3 Suppl):27S-33S.
1996: Sajatovic M; Meltzer H Y
Clozapine-induced myoclonus and generalized seizures.
Biological psychiatry 1996;39(5):367-70.
1996: Meltzer H Y; Fibiger H C
Olanzapine: a new typical antipsychotic drug.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;14(2):83-5.
1996: Sumiyoshi T; Stockmeier C A; Overholser J C; Dilley G E; Meltzer H Y
Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia.
Brain research 1996;708(1-2):209-14.
1996: Sasaki T; Billett E; Petronis A; Ying D; Parsons T; Macciardi F M; Meltzer H Y; Lieberman J; Joffe R T; Ross C A; McInnis M G; Li S H; Kennedy J L
Psychosis and genes with trinucleotide repeat polymorphism.
Human genetics 1996;97(2):244-6.
1996: Maes M; De Meester I; Scharpe S; Desnyder R; Ranjan R; Meltzer H Y
Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs.
Acta psychiatrica Scandinavica 1996;93(1):1-8.
1996: Maes M; Van Gastel A; Meltzer H Y; Cosyns P; Blockx P; Desnyder R
Acute administration of buspirone increases the escape of hypothalamic-pituitary-adrenal-axis hormones from suppression by dexamethasone in depression.
Psychoneuroendocrinology 1996;21(1):67-81.
1996: Kohen R; Metcalf M A; Khan N; Druck T; Huebner K; Lachowicz J E; Meltzer H Y; Sibley D R; Roth B L; Hamblin M W
Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor.
Journal of neurochemistry 1996;66(1):47-56.
1996: Meltzer H Y; Maes M
Effect of pindolol on hormone secretion and body temperature: partial agonist effects.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(1-2):77-88.
1995: Kennedy J L; Billett E A; Macciardi F M; Verga M; Parsons T J; Meltzer H Y; Lieberman J; Buchanan J A
Association study of dopamine D3 receptor gene and schizophrenia.
American journal of medical genetics 1995;60(6):558-62.
1995: Ichikawa J; Kuroki T; Kitchen M T; Meltzer H Y
R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens.
European journal of pharmacology 1995;287(2):179-84.
1995: Ichikawa J; Meltzer H Y
DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum.
Brain research 1995;698(1-2):204-8.
1995: Meltzer H Y; Maes M
Effects of ipsapirone on plasma cortisol and body temperature in major depression.
Biological psychiatry 1995;38(7):450-7.
1995: Maes M; Goossens F; Scharpé S; Calabrese J; Desnyder R; Meltzer H Y
Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs.
Psychiatry research 1995;58(3):217-25.
1995: Petronis A; Macciardi F; Athanassiades A; Paterson A D; Verga M; Meltzer H Y; Cola P; Buchanan J A; Van Tol H H; Kennedy J L
Association study between the dopamine D4 receptor gene and schizophrenia.
American journal of medical genetics 1995;60(5):452-5.
1995: Masellis M; Paterson A D; Badri F; Lieberman J A; Meltzer H Y; Cavazzoni P; Kennedy J L
Genetic variation of 5-HT2A receptor and response to clozapine.
Lancet 1995;346(8982):1108.
1995: Ordway G A; Stockmeier C A; Meltzer H Y; Overholser J C; Jaconetta S; Widdowson P S
Neuropeptide Y in frontal cortex is not altered in major depression.
Journal of neurochemistry 1995;65(4):1646-50.
1995: Meltzer H Y; Maes M
Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men.
Psychiatry research 1995;58(2):89-98.
1995: Elkis H; Friedman L; Wise A; Meltzer H Y
Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Comparisons with controls or patients with schizophrenia.
Archives of general psychiatry 1995;52(9):735-46.
1995: Meltzer H Y; Maes M
Effect of pindolol pretreatment on MK-212-induced plasma cortisol and prolactin responses in normal men.
Biological psychiatry 1995;38(5):310-8.
1995: Maes M; Meltzer H Y; Bosmans E; Bergmans R; Vandoolaeghe E; Ranjan R; Desnyder R
Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression.
Journal of affective disorders 1995;34(4):301-9.
1995: Roth B L; Tandra S; Burgess L H; Sibley D R; Meltzer H Y
D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs.
Psychopharmacology 1995;120(3):365-8.
1995: Ichikawa J; Meltzer H Y
Effect of antidepressants on striatal and accumbens extracellular dopamine levels.
European journal of pharmacology 1995;281(3):255-61.
1995: Hudgel D W; Gordon E A; Meltzer H Y
Abnormal serotonergic stimulation of cortisol production in obstructive sleep apnea.
American journal of respiratory and critical care medicine 1995;152(1):186-92.
1995: Meltzer H Y
Clozapine: is another view valid?
The American journal of psychiatry 1995;152(6):821-5.
1995: Sumiyoshi T; Stockmeier C A; Overholser J C; Thompson P A; Meltzer H Y
Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression.
Brain research 1995;681(1-2):109-16.
1995: Meltzer H Y
Neuroleptic withdrawal in schizophrenic patients. An idea whose time has come.
Archives of general psychiatry 1995;52(3):200-2.
1995: Friedman L; Jesberger J A; Siever L J; Thompson P; Mohs R; Meltzer H Y
Smooth pursuit performance in patients with affective disorders or schizophrenia and normal controls: analysis with specific oculomotor measures, RMS error and qualitative ratings.
Psychological medicine 1995;25(2):387-403.
1995: Maes M; Bosmans E; Calabrese J; Smith R; Meltzer H Y
Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers.
Journal of psychiatric research 1995;29(2):141-52.
1995: Meltzer H Y; Okayli G
Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment.
The American journal of psychiatry 1995;152(2):183-90.
1995: Meltzer H Y; Kennedy J; Dai J; Parsa M; Riley D
Plasma clozapine levels and the treatment of L-DOPA-induced psychosis in Parkinson's disease. A high potency effect of clozapine.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1995;12(1):39-45.
1995: Meltzer H Y
The role of serotonin in schizophrenia and the place of serotonin-dopamine antagonist antipsychotics.
Journal of clinical psychopharmacology 1995;15(1 Suppl 1):2S-3S.
1995: Friedman L; Kenny J T; Jesberger J A; Choy M M; Meltzer H Y
Relationship between smooth pursuit eye-tracking and cognitive performance in schizophrenia.
Biological psychiatry 1995;37(4):265-72.
1995: Altamura C; Maes M; Dai J; Meltzer H Y
Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1995;5 Suppl():71-5.
1995: Maes M; Meltzer H Y; D'Hondt P; Cosyns P; Blockx P
Effects of serotonin precursors on the negative feedback effects of glucocorticoids on hypothalamic-pituitary-adrenal axis function in depression.
Psychoneuroendocrinology 1995;20(2):149-67.
1995: Maes M; Meltzer H Y; Buckley P; Bosmans E
Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression.
European archives of psychiatry and clinical neuroscience 1995;244(6):325-9.
1995: Maes M; Bosmans E; Meltzer H Y
Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol.
European archives of psychiatry and clinical neuroscience 1995;245(3):172-8.
1995: Meltzer H Y
Role of serotonin in the action of atypical antipsychotic drugs.
Clinical neuroscience (New York, N.Y.) 1995;3(2):64-75.
1994: Meltzer H Y
Serotonin2A receptors in schizophrenia: relation to suicide.
Archives of general psychiatry 1994;51(12):1003-4.
1994: Maes M; Meltzer H; Cosyns P; Calabrese J; D'Hondt P; Blockx P
Adrenocorticotropic hormone, beta-endorphin and cortisol responses to oCRH in unipolar depressed patients pretreated with dexamethasone.
Progress in neuro-psychopharmacology & biological psychiatry 1994;18(8):1273-92.
1994: Maes M; Scharpé S; Meltzer H Y; Okayli G; Bosmans E; D'Hondt P; Vanden Bossche B V; Cosyns P
Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response.
Psychiatry research 1994;54(2):143-60.
1994: Maes M; Delanghe J; Meltzer H Y; Scharpé S; D'Hondt P; Cosyns P
Lower degree of esterification of serum cholesterol in depression: relevance for depression and suicide research.
Acta psychiatrica Scandinavica 1994;90(4):252-8.
1994: Thompson P A; Buckley P F; Meltzer H Y
The brief psychiatric rating scale: effect of scaling system on clinical response assessment.
Journal of clinical psychopharmacology 1994;14(5):344-6.
1994: Vrtunski P B; Alphs L D; Meltzer H Y
Motor mechanisms in schizophrenic patients with tardive dyskinesia.
Psychiatry research 1994;54(1):71-86.
1994: Kimmel S E; Calabrese J R; Woyshville M J; Meltzer H Y
Clozapine in treatment-refractory mood disorders.
The Journal of clinical psychiatry 1994;55 Suppl B():91-3.
1994: Lee M A; Thompson P A; Meltzer H Y
Effects of clozapine on cognitive function in schizophrenia.
The Journal of clinical psychiatry 1994;55 Suppl B():82-7.
1994: Yamamoto B K; Pehek E A; Meltzer H Y
Brain region effects of clozapine on amino acid and monoamine transmission.
The Journal of clinical psychiatry 1994;55 Suppl B():8-14.
1994: Meltzer H Y
An overview of the mechanism of action of clozapine.
The Journal of clinical psychiatry 1994;55 Suppl B():47-52.
1994: Meltzer H Y; Cola P A
The pharmacoeconomics of clozapine: a review.
The Journal of clinical psychiatry 1994;55 Suppl B():161-5.
1994: Buckley P; Thompson P A; Way L; Meltzer H Y
Substance abuse and clozapine treatment.
The Journal of clinical psychiatry 1994;55 Suppl B():114-6.
1994: Buckley P F; Sajatovic M; Meltzer H Y
Treatment of delusional disorders with clozapine.
The American journal of psychiatry 1994;151(9):1394-5.
1994: Meltzer H Y; Ranjan R
Valproic acid treatment of clozapine-induced myoclonus.
The American journal of psychiatry 1994;151(8):1246-7.
1994: Friedman L; Jesberger J A; Meltzer H Y
The effect of apomorphine, MK-212 (6-chloro-2-[1-piperazinyl]-pyrazine) and placebo on smooth pursuit gain and corrective saccades in normal subjects.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1994;11(1):49-62.
1994: Hasegawa M; Cola P A; Meltzer H Y
Plasma clozapine and desmethylclozapine levels in clozapine-induced agranulocytosis.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1994;11(1):45-7.
1994: Maes M; Meltzer H Y; Stevens W; Calabrese J; Cosyns P
Natural killer cell activity in major depression: relation to circulating natural killer cells, cellular indices of the immune response, and depressive phenomenology.
Progress in neuro-psychopharmacology & biological psychiatry 1994;18(4):717-30.
1994: Thompson P A; Maes M; Meltzer H Y
Effect of the placebo control condition in neuroendocrine challenge studies.
Psychiatry research 1994;52(3):317-26.
1994: Lee M A; Meltzer H Y
Blunted oral body temperature response to MK-212 in cocaine addicts.
Drug and alcohol dependence 1994;35(3):217-22.
1994: Maes M; Calabrese J; Meltzer H Y
The relevance of the in- versus outpatient status for studies on HPA-axis in depression: spontaneous hypercortisolism is a feature of major depressed inpatients and not of major depression per se.
Progress in neuro-psychopharmacology & biological psychiatry 1994;18(3):503-17.
1994: Maes M; Meltzer H Y; Bosmans E
Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine.
Acta psychiatrica Scandinavica 1994;89(5):346-51.
1994: Meltzer H Y; Maes M
Effect of pindolol on the L-5-HTP-induced increase in plasma prolactin and cortisol concentrations in man.
Psychopharmacology 1994;114(4):635-43.
1994: Maes M; Goossens F; Scharpé S; Meltzer H Y; D'Hondt P; Cosyns P
Lower serum prolyl endopeptidase enzyme activity in major depression: further evidence that peptidases play a role in the pathophysiology of depression.
Biological psychiatry 1994;35(8):545-52.
1994: Arora R C; Meltzer H Y
Effect of clozapine treatment on serotonin-2-receptor binding in the blood platelets of schizophrenic patients.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1994;10(2):109-14.
1994: Meltzer H Y; Chai B L; Thompson P A; Yamamoto B K
Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
The Journal of pharmacology and experimental therapeutics 1994;268(3):1452-61.
1994: Buckley P; Thompson P; Way L; Meltzer H Y
Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy.
The American journal of psychiatry 1994;151(3):385-9.
1994: Haacke E M; Hopkins A; Lai S; Buckley P; Friedman L; Meltzer H; Hedera P; Friedland R; Klein S; Thompson L
2D and 3D high resolution gradient echo functional imaging of the brain: venous contributions to signal in motor cortex studies.
NMR in biomedicine 1994;7(1-2):54-62.
1994: Gerson S L; Arce C; Meltzer H Y
N-desmethylclozapine: a clozapine metabolite that suppresses haemopoiesis.
British journal of haematology 1994;86(3):555-61.
1994: Meltzer H Y; Maes M
Effects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjects.
Biological psychiatry 1994;35(5):316-23.
1994: Maes M; Scharpé S; Cosyns P; Meltzer H
Relationships between basal hypothalamic-pituitary-thyroid-axis activity and plasma haptoglobin levels in depression.
Journal of psychiatric research 1994;28(2):123-34.
1994: Roth B L; Craigo S C; Choudhary M S; Uluer A; Monsma F J; Shen Y; Meltzer H Y; Sibley D R
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
The Journal of pharmacology and experimental therapeutics 1994;268(3):1403-10.
1994: Maes M; Meltzer H Y; Stevens W; Cosyns P; Blockx P
Multiple reciprocal relationships between in vivo cellular immunity and hypothalamic-pituitary-adrenal axis in depression.
Psychological medicine 1994;24(1):167-77.
1994: Maes M; Delanghe J; Scharpé S; Meltzer H Y; Cosyns P; Suy E; Bosmans E
Haptoglobin phenotypes and gene frequencies in unipolar major depression.
The American journal of psychiatry 1994;151(1):112-6.
1994: Sajatovic M; Ramirez L F; Kenny J T; Meltzer H Y
The use of clozapine in borderline-intellectual-functioning and mentally retarded schizophrenic patients.
Comprehensive psychiatry 1994;35(1):29-33.
1994: Maes M; Calabrese J; Lee M; Meltzer H Y
Effects of age on spontaneous cortisolaemia of normal volunteers and depressed patients.
Psychoneuroendocrinology 1994;19(1):79-84.
1994: Maes M; Meltzer H; Blockx P; Cosyns P; Calabrese J
Ultrasensitive assay for measuring the intact (1-39) ACTH molecule: an asset in depression research.
Neuropsychobiology 1994;29(4):168-73.
1994: Maes M; Meltzer H Y; Cosyns P; Schotte C
Evidence for the existence of major depression with and without anxiety features.
Psychopathology 1994;27(1-2):1-13.
1994: Maes M; Meltzer H Y; Bosmans E
Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1 beta and IL-6 concentrations.
Neuropsychobiology 1994;30(2-3):57-60.
1994: Meltzer H Y; Lee M A; Ranjan R
Recent advances in the pharmacotherapy of schizophrenia.
Acta psychiatrica Scandinavica. Supplementum 1994;384():95-101.
1993: Hasegawa M; Gutierrez-Esteinou R; Way L; Meltzer H Y
Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking.
Journal of clinical psychopharmacology 1993;13(6):383-90.
1993: Hagger C; Buckley P; Kenny J T; Friedman L; Ubogy D; Meltzer H Y
Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.
Biological psychiatry 1993;34(10):702-12.
1993: Maes M; Scharpé S; Meltzer H Y; Cosyns P
Relationships between increased haptoglobin plasma levels and activation of cell-mediated immunity in depression.
Biological psychiatry 1993;34(10):690-701.
1993: Meltzer H Y; Cola P; Way L; Thompson P A; Bastani B; Davies M A; Snitz B
Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia.
The American journal of psychiatry 1993;150(11):1630-8.
1993: Maes M; Meltzer H Y; Scharpé S; Bosmans E; Suy E; De Meester I; Calabrese J; Cosyns P
Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression.
Psychiatry research 1993;49(2):151-65.
1993: Vrtunski P B; Lewis K L; Meltzer H Y
Visual feedback in force control of schizophrenics.
Biological psychiatry 1993;34(9):667-70.
1993: Maes M; Scharpé S; Meltzer H Y; Bosmans E; Suy E; Calabrese J; Cosyns P
Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression.
Psychiatry research 1993;49(1):11-27.
1993: Lai S; Hopkins A L; Haacke E M; Li D; Wasserman B A; Buckley P; Friedman L; Meltzer H; Hedera P; Friedland R
Identification of vascular structures as a major source of signal contrast in high resolution 2D and 3D functional activation imaging of the motor cortex at 1.5T: preliminary results.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 1993;30(3):387-92.
1993: Thompson P A; Meltzer H Y
Positive, negative, and disorganisation factors from the Schedule for Affective Disorders and Schizophrenia and the Present State Examination. A three-factor solution.
The British journal of psychiatry : the journal of mental science 1993;163():344-51.
1993: Maes M; Cosyns P; Meltzer H Y; De Meyer F; Peeters D
Seasonality in violent suicide but not in nonviolent suicide or homicide.
The American journal of psychiatry 1993;150(9):1380-5.
1993: Maes M; Meltzer H Y; Suy E; De Meyer F
Seasonality in severity of depression: relationships to suicide and homicide occurrence.
Acta psychiatrica Scandinavica 1993;88(3):156-61.
1993: Stockmeier C A; DiCarlo J J; Zhang Y; Thompson P; Meltzer H Y
Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
The Journal of pharmacology and experimental therapeutics 1993;266(3):1374-84.
1993: Pehek E A; Meltzer H Y; Yamamoto B K
The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux.
European journal of pharmacology 1993;240(1):107-9.
1993: Jaskiw G E; Hussain G; Meltzer H Y
Frontal cortex lesions modify the cataleptogenic properties of haloperidol but not of clozapine.
Biological psychiatry 1993;34(3):188-90.
1993: Maes M; Bosmans E; Meltzer H Y; Scharpé S; Suy E
Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?
The American journal of psychiatry 1993;150(8):1189-93.
1993: Maes M; Dierckx R; Meltzer H Y; Ingels M; Schotte C; Vandewoude M; Calabrese J; Cosyns P
Regional cerebral blood flow in unipolar depression measured with Tc-99m-HMPAO single photon emission computed tomography: negative findings.
Psychiatry research 1993;50(2):77-88.
1993: Maes M; Meltzer H Y; Scharpé S; Cooreman W; Uyttenbroeck W; Suy E; Vandervorst C; Calabrese J; Raus J; Cosyns P
Psychomotor retardation, anorexia, weight loss, sleep disturbances, and loss of energy: psychopathological correlates of hyperhaptoglobinemia during major depression.
Psychiatry research 1993;47(3):229-41.
1993: Meltzer H Y
New drugs for the treatment of schizophrenia.
The Psychiatric clinics of North America 1993;16(2):365-85.
1993: Arora R C; Meltzer H Y
Serotonin2 receptor binding in blood platelets of schizophrenic patients.
Psychiatry research 1993;47(2):111-9.
1993: Maes M; De Meyer F; Peeters D; Meltzer H; Schotte C; Scharpe S; Cosyns P
The periodicities in and biometeorological relationships with bed occupancy of an acute psychiatric ward in Antwerp, Belgium.
International journal of biometeorology 1993;37(2):78-82.
1993: Parsa M A; al-Lahham Y H; Ramirez L F; Meltzer H Y
Prolonged psychotic relapse after abrupt clozapine withdrawal.
Journal of clinical psychopharmacology 1993;13(2):154-5.
1993: Maes M; Meltzer H; Cosyns P; Calabrese J; D'Hondt P; Blockx P; Vandervorst C; Raus J
Pituitary and adrenal hormone responsiveness to Synacthen in melancholic subjects versus subjects with minor depression.
Biological psychiatry 1993;33(8-9):624-9.
1993: Buckley P F; Meltzer H Y
Clozapine and NMS.
The British journal of psychiatry : the journal of mental science 1993;162():566.
1993: Maes M; Meltzer H Y; Suy E; Minner B; Calabrese J; Cosyns P
Sleep disorders and anxiety as symptom profiles of sympathoadrenal system hyperactivity in major depression.
Journal of affective disorders 1993;27(3):197-207.
1993: Maes M; Meltzer H; Jacobs J; Suy E; Calabrese J; Minner B; Raus J
Autoimmunity in depression: increased antiphospholipid autoantibodies.
Acta psychiatrica Scandinavica 1993;87(3):160-6.
1993: Parsa M A; Simon M; Dubrow C; Ramirez L F; Meltzer H Y
Psychiatric manifestations of olivo-ponto-cerebellar atrophy and treatment with clozapine.
International journal of psychiatry in medicine 1993;23(2):149-56.
1993: Maes M; Meltzer H Y; Cosyns P; Suy E; Schotte C
An evaluation of basal hypothalamic-pituitary-thyroid axis function in depression: results of a large-scaled and controlled study.
Psychoneuroendocrinology 1993;18(8):607-20.
1993: Meltzer H Y
Serotonin receptors and antipsychotic drug action.
Psychopharmacology series 1993;10():70-81.
1993: Meltzer H Y; Maes M; Lee M A
The cimetidine-induced increase in prolactin secretion in schizophrenia: effect of clozapine.
Psychopharmacology 1993;112(1 Suppl):S95-104.
1992: Brockington I; Roper A; Edmunds E; Kaufman C; Meltzer H Y
A longitudinal psychopathological schedule.
Psychological medicine 1992;22(4):1035-43.
1992: Maes M; De Meyer F; Peeters D; Meltzer H; Cosyns P; Schotte C
Seasonal variation and meteotropism in various self-rated psychological and physiological features of a normal couple.
International journal of biometeorology 1992;36(4):195-200.
1992: Yamamoto B K; Meltzer H Y
The effect of the atypical antipsychotic drug, amperozide, on carrier-mediated striatal dopamine release measured in vivo.
The Journal of pharmacology and experimental therapeutics 1992;263(1):180-5.
1992: Maes M; Scharpé S; Meltzer H Y; Suy E; Cosyns P; Calabrese J
Lower angiotensin I converting enzyme activity in melancholic subjects: a pilot study.
Biological psychiatry 1992;32(7):621-4.
1992: Ohmori T; Arora R C; Meltzer H Y
Serotonergic measures in suicide brain: the concentration of 5-HIAA, HVA, and tryptophan in frontal cortex of suicide victims.
Biological psychiatry 1992;32(1):57-71.
1992: Meltzer H Y; Stockmeier C A
In vivo occupancy of dopamine receptors by antipsychotic drugs.
Archives of general psychiatry 1992;49(7):588-9.
1992: Friedman L; Abel L A; Jesberger J A; Malki A; Meltzer H Y
Saccadic intrusions into smooth pursuit in patients with schizophrenia or affective disorder and normal controls.
Biological psychiatry 1992;31(11):1110-8.
1992: Chai B; Meltzer H Y
The effect of chronic clozapine on basal dopamine release and apomorphine-induced DA release in the striatum and nucleus accumbens as measured by in vivo brain microdialysis.
Neuroscience letters 1992;140(1):47-50.
1992: Ichikawa J; Meltzer H Y
Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens.
Journal of neurochemistry 1992;58(6):2285-91.
1992: Maes M; Stevens W; DeClerck L; Peeters D; Bridts C; Schotte C; Meltzer H; Scharpé S; Cosyns P
Neutrophil chemotaxis, phagocytosis, and superoxide release in depressive illness.
Biological psychiatry 1992;31(12):1220-4.
1992: Nerozzi D; Magnani A; Dastoli C; Ferri E; Capesciotti G; Antonozzi I; Frajese G; Meltzer H Y
Prolactin responses to domperidone in chronic schizophrenia.
Psychiatry research 1992;42(2):159-69.
1992: Meltzer H Y
Dimensions of outcome with clozapine.
The British journal of psychiatry. Supplement 1992;(17):46-53.
1992: Meltzer H Y; Zhang Y; Stockmeier C A
Effect of amperozide on rat cortical 5-HT2 and striatal and limbic dopamine D2 receptor occupancy: implications for antipsychotic action.
European journal of pharmacology 1992;216(1):67-71.
1992: Meltzer H Y
The importance of serotonin-dopamine interactions in the action of clozapine.
The British journal of psychiatry. Supplement 1992;(17):22-9.
1992: Lee H S; Bastani B; Friedman L; Ramirez L; Meltzer H Y
Effect of the serotonin agonist, MK-212, on body temperature in schizophrenia.
Biological psychiatry 1992;31(5):460-70.
1992: Ichikawa J; Meltzer H Y
The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
Brain research 1992;574(1-2):98-104.
1992: Roth B L; Ciaranello R D; Meltzer H Y
Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors.
The Journal of pharmacology and experimental therapeutics 1992;260(3):1361-5.
1992: Ambrosini P J; Metz C; Arora R C; Lee J C; Kregel L; Meltzer H Y
Platelet imipramine binding in depressed children and adolescents.
Journal of the American Academy of Child and Adolescent Psychiatry 1992;31(2):298-305.
1992: Meltzer H Y; Gudelsky G A
Dopaminergic and serotonergic effects of clozapine. Implications for a unique clinical profile.
Arzneimittel-Forschung 1992;42(2A):268-72.
1992: Meltzer H Y; Lee H S; Nash J F
Effect of buspirone on prolactin secretion is not mediated by 5-HT-1a receptor stimulation.
Archives of general psychiatry 1992;49(2):163-4.
1992: Friedman L; Jesberger J A; Abel L A; Meltzer H Y
Catch-up saccade amplitude is related to square wave jerk rate.
Investigative ophthalmology & visual science 1992;33(1):228-33.
1992: Friedman L; Jesberger J A; Meltzer H Y
Effect of typical antipsychotic medications and clozapine on smooth pursuit performance in patients with schizophrenia.
Psychiatry research 1992;41(1):25-36.
1992: Mikuni M; Kagaya A; Takahashi K; Meltzer H Y
Serotonin but not norepinephrine-induced calcium mobilization of platelets is enhanced in affective disorders.
Psychopharmacology 1992;106(3):311-4.
1992: Gerson S L; Meltzer H
Mechanisms of clozapine-induced agranulocytosis.
Drug safety : an international journal of medical toxicology and drug experience 1992;7 Suppl 1():17-25.
1992: Attkisson C; Cook J; Karno M; Lehman A; McGlashan T H; Meltzer H Y; O'Connor M; Richardson D; Rosenblatt A; Wells K
Clinical services research.
Schizophrenia bulletin 1992;18(4):561-626.
1992: Meltzer H Y
Treatment of the neuroleptic-nonresponsive schizophrenic patient.
Schizophrenia bulletin 1992;18(3):515-42.
1991: Calabrese J R; Meltzer H Y; Markovitz P J
Clozapine prophylaxis in rapid cycling bipolar disorder.
Journal of clinical psychopharmacology 1991;11(6):396-7.
1991: Meltzer H Y; Nash J F
Effects of antipsychotic drugs on serotonin receptors.
Pharmacological reviews 1991;43(4):587-604.
1991: Lee M A; Meltzer H Y
Neuroendocrine responses to serotonergic agents in alcoholics.
Biological psychiatry 1991;30(10):1017-30.
1991: Parsa M A; Ramirez L F; Loula E C; Meltzer H Y
Effect of clozapine on psychotic depression and parkinsonism.
Journal of clinical psychopharmacology 1991;11(5):330-1.
1991: Friedman L; Jesberger J A; Meltzer H Y
A model of smooth pursuit performance illustrates the relationship between gain, catch-up saccade rate, and catch-up saccade amplitude in normal controls and patients with schizophrenia.
Biological psychiatry 1991;30(6):537-56.
1991: Arora R C; Emery O B; Meltzer H Y
Serotonin uptake in the blood platelets of Alzheimer's disease patients.
Neurology 1991;41(8):1307-9.
1991: Markovitz P J; Calabrese J R; Schulz S C; Meltzer H Y
Fluoxetine in the treatment of borderline and schizotypal personality disorders.
The American journal of psychiatry 1991;148(8):1064-7.
1991: Gerson S L; Lieberman J A; Friedenberg W R; Lee D; Marx J J; Meltzer H
Polypharmacy in fatal clozapine-associated agranulocytosis.
Lancet 1991;338(8761):262-3.
1991: Bastani B; Arora R C; Meltzer H Y
Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive disorder patients.
Biological psychiatry 1991;30(2):131-9.
1991: Lee H S; Kwon K Y; Alphs L D; Meltzer H Y
Effect of clozapine on psychogenic polydipsia in chronic schizophrenia.
Journal of clinical psychopharmacology 1991;11(3):222-3.
1991: Abel L A; Friedman L; Jesberger J; Malki A; Meltzer H Y
Quantitative assessment of smooth pursuit gain and catch-up saccades in schizophrenia and affective disorders.
Biological psychiatry 1991;29(11):1063-72.
1991: Friedman L; Knutson L; Shurell M; Meltzer H Y
Prefrontal sulcal prominence is inversely related to response to clozapine in schizophrenia.
Biological psychiatry 1991;29(9):865-77.
1991: Meltzer H Y
Beyond serotonin.
The Journal of clinical psychiatry 1991;52 Suppl():58-62.
1991: Arora R C; Meltzer H Y
Laterality and 3H-imipramine binding: studies in the frontal cortex of normal controls and suicide victims.
Biological psychiatry 1991;29(10):1016-22.
1991: Vrtunski P B; Alphs L D; Meltzer H Y
Isometric force control in schizophrenic patients with tardive dyskinesia.
Psychiatry research 1991;37(1):57-72.
1991: Alphs L D; Meltzer H Y; Bastani B; Ramirez L F
Side effects of clozapine and their management.
Pharmacopsychiatry 1991;24(2):46.
1991: Meltzer H Y; Alphs L D; Bastani B; Ramirez L F; Kwon K
Clinical efficacy of clozapine in the treatment of schizophrenia.
Pharmacopsychiatry 1991;24(2):44-5.
1991: Stockmeier C A; Meltzer H Y
Beta-adrenergic receptor binding in frontal cortex of suicide victims.
Biological psychiatry 1991;29(2):183-91.
1991: Ichikawa J; Meltzer H Y
Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens.
The Journal of pharmacology and experimental therapeutics 1991;256(1):348-57.
1991: Nash J F; Arora R C; Schreiber M A; Meltzer H Y
Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats.
Biochemical pharmacology 1991;41(1):79-84.
1991: Sajatovic M; Verbanac P; Ramirez L F; Meltzer H Y
Clozapine treatment of psychiatric symptoms resistant to neuroleptic treatment in patients with Huntington's chorea.
Neurology 1991;41(1):156.
1991: Lee M A; Nash J F; Barnes M; Meltzer H Y
Inhibitory effect of ritanserin on the 5-hydroxytryptophan-mediated cortisol, ACTH and prolactin secretion in humans.
Psychopharmacology 1991;103(2):258-64.
1991: Matsubara S; Arora R C; Meltzer H Y
Serotonergic measures in suicide brain: 5-HT1A binding sites in frontal cortex of suicide victims.
Journal of neural transmission. General section 1991;85(3):181-94.
1991: Kenny J T; Meltzer H Y
Attention and higher cortical functions in schizophrenia.
The Journal of neuropsychiatry and clinical neurosciences 1991;3(3):269-75.
1991: Lee H S; Meltzer H Y
Buspirone does not produce a 5-HT1A-mediated decrease in temperature in man.
Journal of neural transmission. General section 1991;86(1):71-6.
1991: Meltzer H Y
The mechanism of action of novel antipsychotic drugs.
Schizophrenia bulletin 1991;17(2):263-87.
1991: Arora R C; Meltzer H Y
Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients.
Journal of neural transmission. General section 1991;85(1):19-29.
1990: Parsa M A; Rohr T; Ramirez L F; Meltzer H Y
Neuroleptic malignant syndrome without neuroleptics.
Journal of clinical psychopharmacology 1990;10(6):437-8.
1990: Meltzer H Y
Monitoring clozapine.
Hospital & community psychiatry 1990;41(12):1356-7.
1990: Nerozzi D; Magnani A; Sforza V; Scaramucci E; Cerilli M; Moretti C; Frajese G; Antonozzi I; Meltzer H Y
Plasma prolactin response to domperidone in acute schizophrenia and schizophreniform illness.
Psychiatry research 1990;34(2):139-47.
1990: Bastani B; Nash J F; Meltzer H Y
Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder.
Archives of general psychiatry 1990;47(9):833-9.
1990: Meltzer H Y; Burnett S; Bastani B; Ramirez L F
Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients.
Hospital & community psychiatry 1990;41(8):892-7.
1990: Lee M A; Bowers M M; Nash J F; Meltzer H Y
Neuroendocrine measures of dopaminergic function in chronic cocaine users.
Psychiatry research 1990;33(2):151-9.
1990: Harrow M; Goldberg J F; Grossman L S; Meltzer H Y
Outcome in manic disorders. A naturalistic follow-up study.
Archives of general psychiatry 1990;47(7):665-71.
1990: Arora R C; Meltzer H Y
3H-imipramine binding in the blood platelets of normal twins.
Psychiatry research 1990;32(3):265-73.
1990: Lowy M T; Nash J F; Meltzer H Y
Reserpine-induced DST nonsuppression in rats.
Biological psychiatry 1990;27(5):546-8.
1990: Nash J F; Meltzer H Y; Gudelsky G A
Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalanine accumulation in the striatum and nucleus accumbens.
Journal of neurochemistry 1990;54(3):1062-7.
1990: Ichikawa J; Meltzer H Y
The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studied by in vivo microdialysis.
European journal of pharmacology 1990;176(3):371-4.
1990: Ichikawa J; Meltzer H Y
Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment.
Brain research 1990;507(1):138-42.
1990: Meltzer H Y
Role of serotonin in depression.
Annals of the New York Academy of Sciences 1990;600():486-99; discussion 499-500.
1990: Meltzer H Y
Defining treatment refractoriness in schizophrenia.
Schizophrenia bulletin 1990;16(4):563-5.
1990: Meltzer H Y
Presynaptic receptors. Relevance to psychotropic drug action in man.
Annals of the New York Academy of Sciences 1990;604():353-71.
1989: Helmuth D; Ljaljevic Z; Ramirez L; Meltzer H Y
Choreoathetosis induced by verapamil and lithium treatment.
Journal of clinical psychopharmacology 1989;9(6):454-5.
1989: Arora R C; Meltzer H Y
3H-imipramine binding in the frontal cortex of suicides.
Psychiatry research 1989;30(2):125-35.
1989: Meltzer H Y; Matsubara S; Lee J C
Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.
The Journal of pharmacology and experimental therapeutics 1989;251(1):238-46.
1989: Nash J F; Meltzer H Y; Gudelsky G A
Selective cross-tolerance to 5-HT1A and 5-HT2 receptor-mediated temperature and corticosterone responses.
Pharmacology, biochemistry, and behavior 1989;33(4):781-5.
1989: Meltzer H Y
Duration of a clozapine trial in neuroleptic-resistant schizophrenia.
Archives of general psychiatry 1989;46(7):672.
1989: Arora R C; Meltzer H Y
Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects.
The American journal of psychiatry 1989;146(6):730-6.
1989: Gudelsky G A; Berry S A; Meltzer H Y
Neurotensin activates tuberoinfundibular dopamine neurons and increases serum corticosterone concentrations in the rat.
Neuroendocrinology 1989;49(6):604-9.
1989: Nash J F; Meltzer H Y
Effect of gepirone and ipsapirone on the stimulated and unstimulated secretion of prolactin in the rat.
The Journal of pharmacology and experimental therapeutics 1989;249(1):236-41.
1989: Lowy M T; Nash J F; Meltzer H Y
Selective reduction of striatal type II glucocorticoid receptors in rats by 3,4-methylenedioxymethamphetamine (MDMA).
European journal of pharmacology 1989;163(1):157-61.
1989: Vrtunski P B; Simpson D M; Meltzer H Y
Voluntary movement dysfunction in schizophrenics.
Biological psychiatry 1989;25(5):529-39.
1989: Gudelsky G A; Meltzer H Y
Activation of tuberoinfundibular dopamine neurons following the acute administration of atypical antipsychotics.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1989;2(1):45-51.
1989: Arora R C; Meltzer H Y
Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients.
Life sciences 1989;44(11):725-34.
1989: Meltzer H Y; Bastani B; Kwon K Y; Ramirez L F; Burnett S; Sharpe J
A prospective study of clozapine in treatment-resistant schizophrenic patients. I. Preliminary report.
Psychopharmacology 1989;99 Suppl():S68-72.
1989: Bastani B; Alphs L D; Meltzer H Y
Development of the Clozaril Patient Management System.
Psychopharmacology 1989;99 Suppl():S122-5.
1989: Meltzer H Y
Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia.
Psychopharmacology 1989;99 Suppl():S18-27.
1989: Gudelsky G A; Nash J F; Berry S A; Meltzer H Y
Basic biology of clozapine: electrophysiological and neuroendocrinological studies.
Psychopharmacology 1989;99 Suppl():S13-7.
1989: Meltzer H Y; Matsubara S; Lee J C
The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs.
Psychopharmacology bulletin 1989;25(3):390-2.
1989: Gudelsky G A; Berry S A; Meltzer H Y
Actions of typical and atypical antipsychotics on tuberoinfundibular dopamine neurons.
Psychopharmacology bulletin 1989;25(3):377-82.
1989: Meltzer H Y; Zureick J
Negative symptoms in schizophrenia: a target for new drug development.
Psychopharmacology series 1989;7():68-77.
1989: Meltzer H Y; Koenig J I; Nash J F; Gudelsky G A
Melperone and clozapine: neuroendocrine effects of atypical neuroleptic drugs.
Acta psychiatrica Scandinavica. Supplementum 1989;352():24-9.
1989: Matsubara S; Meltzer H Y
Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex.
Life sciences 1989;45(15):1397-406.
1989: Meltzer H Y; Bastani B; Ramirez L; Matsubara S
Clozapine: new research on efficacy and mechanism of action.
European archives of psychiatry and neurological sciences 1989;238(5-6):332-9.
1988: Meltzer H Y
Race and platelet MAO activity in schizophrenic patients.
Psychiatry research 1988;26(3):337.
1988: Lowy M T; Reder A T; Gormley G J; Meltzer H Y
Comparison of in vivo and in vitro glucocorticoid sensitivity in depression: relationship to the dexamethasone suppression test.
Biological psychiatry 1988;24(6):619-30.
1988: Kane J; Honigfeld G; Singer J; Meltzer H
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.
Archives of general psychiatry 1988;45(9):789-96.
1988: Meltzer H Y
New insights into schizophrenia through atypical antipsychotic drugs.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1988;1(3):193-6.
1988: Nash J F; Meltzer H Y; Gudelsky G A
Antagonism of serotonin receptor mediated neuroendocrine and temperature responses by atypical neuroleptics in the rat.
European journal of pharmacology 1988;151(3):463-9.
1988: Meltzer H Y; Arora R C
Genetic control of serotonin uptake in blood platelets: a twin study.
Psychiatry research 1988;24(3):263-9.
1988: Meltzer H Y; Lowy M T; Locascio J J
Platelet MAO activity and the cortisol response to dexamethasone in major depression.
Biological psychiatry 1988;24(2):129-42.
1988: Nash J F; Meltzer H Y; Gudelsky G A
Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.
The Journal of pharmacology and experimental therapeutics 1988;245(3):873-9.
1988: Silverstein M L; McDonald C; Meltzer H Y
Differential patterns of neuropsychological deficit in psychiatric disorders.
Journal of clinical psychology 1988;44(3):412-5.
1988: Zureick J L; Meltzer H Y
Platelet MAO activity in hallucinating and paranoid schizophrenics: a review and meta-analysis.
Biological psychiatry 1988;24(1):63-78.
1988: Lowy M T; Meltzer H Y
Stimulation of serum cortisol and prolactin secretion in humans by MK-212, a centrally active serotonin agonist.
Biological psychiatry 1988;23(8):818-28.
1988: Koenig J I; Meltzer H Y; Gudelsky G A
5-Hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone.
Pharmacology, biochemistry, and behavior 1988;29(4):711-5.
1988: Locascio J J; Lee J; Meltzer H Y
Importance of adjusting for correlated concomitant variables in psychiatric research.
Psychiatry research 1988;23(3):311-27.
1988: Metz J T; Holcomb H H; Meltzer H Y
Effect of 5-hydroxytryptophan on H-reflex recovery curves in normal subjects and patients with affective disorders.
Biological psychiatry 1988;23(6):602-11.
1988: Arora R C; Meltzer H Y
Effect of desipramine treatment on 3H-imipramine binding in the blood platelets of depressed patients.
Biological psychiatry 1988;23(4):397-404.
1988: Arora R C; Meltzer H Y
Seasonal variation of imipramine binding in the blood platelets of normal controls and depressed patients.
Biological psychiatry 1988;23(3):217-26.
1988: Breslau N; Meltzer H Y
Validity of subtyping psychotic depression: examination of phenomenology and demographic characteristics.
The American journal of psychiatry 1988;145(1):35-40.
1988: Kane J M; Honigfeld G; Singer J; Meltzer H
Clozapine in treatment-resistant schizophrenics.
Psychopharmacology bulletin 1988;24(1):62-7.
1988: Gudelsky G A; Koenig J I; Koyama T; Meltzer H Y
Activity of tuberoinfundibular dopaminergic neurons and concentrations of serum prolactin in the rat following lithium administration.
Psychopharmacology 1988;94(1):92-6.
1988: Barchas J D; Hadley S W; Detre T; Endicott J; Glover R; King R; Meltzer H Y; Sackeim H; Strauss J S; Wahl P
A national plan for schizophrenia research: panel recommendations. Research resources.
Schizophrenia bulletin 1988;14(3):439-61.
1987: Meltzer H Y; Zureick J L
Relationship of auditory hallucinations and paranoia to platelet MAO activity in schizophrenics: sex and race interactions.
Psychiatry research 1987;22(2):99-109.
1987: Kettering R L; Harrow M; Grossman L; Meltzer H Y
The prognostic relevance of delusions in depression: a follow-up study.
The American journal of psychiatry 1987;144(9):1154-60.
1987: Gudelsky G A; Koenig J I; Meltzer H Y
Selective desensitization of serotonin (5-HT) receptor-mediated hyperthermia by mianserin and other 5-HT antagonists.
Neuropharmacology 1987;26(7A):707-12.
1987: Arora R C; Kuncl R W; Morgan J; Cohen L; Meltzer H Y
Serotonin uptake in blood platelets of Duchenne muscular dystrophy patients.
Muscle & nerve 1987;10(4):359-62.
1987: Reder A T; Lowy M T; Meltzer H Y; Antel J P
Dexamethasone suppression test abnormalities in multiple sclerosis: relation to ACTH therapy.
Neurology 1987;37(5):849-53.
1987: Koenig J I; Gudelsky G A; Meltzer H Y
Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation.
European journal of pharmacology 1987;137(1):1-8.
1987: Lowy M T; Meltzer H Y
Dexamethasone bioavailability: implications for DST research.
Biological psychiatry 1987;22(3):373-85.
1987: Koyama T; Lowy M T; Meltzer H Y
5-Hydroxytryptophan-induced cortisol response and CSF 5-HIAA in depressed patients.
The American journal of psychiatry 1987;144(3):334-7.
1987: Meltzer H Y
Biological studies in schizophrenia.
Schizophrenia bulletin 1987;13(1):77-111.
1987: Passaro E A; Meltzer H Y; Gudelsky G A
Effects of acute and chronic dexamethasone treatment on stimulated prolactin secretion in the rat.
Endocrine research 1987;13(2):173-82.
1987: Gudelsky G A; Koenig J I; Simonovic M; Koyama T; Ohmori T; Meltzer H Y
Differential effects of haloperidol, clozapine, and fluperlapine on tuberoinfundibular dopamine neurons and prolactin secretion in the rat.
Journal of neural transmission 1987;68(3-4):227-40.
1987: Meltzer H Y; Lowy M T; Koenig J I
The hypothalamic-pituitary-adrenal axis in depression.
Advances in biochemical psychopharmacology 1987;43():165-82.
1987: Meltzer H Y
Effect of neuroleptics on the schizophrenic syndrome.
Psychopharmacology series 1987;3():255-65.
1986: Arora R C; Meltzer H Y
Effect of subchronic treatment with imipramine, chlorpromazine and the combination on 3H-imipramine binding in rat blood platelets and frontal cortex.
Life sciences 1986;39(24):2289-96.
1986: Gudelsky G A; Koenig J I; Meltzer H Y
Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors.
Neuropharmacology 1986;25(12):1307-13.
1986: Meltzer H Y; Sommers A A; Luchins D J
The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia.
Journal of clinical psychopharmacology 1986;6(6):329-38.
1986: Arora R C; Locascio J J; Meltzer H Y
3H-imipramine binding in blood platelets of schizophrenic patients.
Psychiatry research 1986;19(3):215-24.
1986: Harrow M; Grossman L S; Silverstein M L; Meltzer H Y; Kettering R L
A longitudinal study of thought disorder in manic patients.
Archives of general psychiatry 1986;43(8):781-5.
1986: Meltzer H Y; Umberköman-Wiita B; Robertson A G; Tricou B J; Lowy M
Correction and amplification: cortisol response to 5-HTP.
Archives of general psychiatry 1986;43(8):815.
1986: Koenig J I; Meltzer H Y; Devane G D; Gudelsky G A
The concentration of arginine vasopressin in pituitary stalk plasma of the rat after adrenalectomy or morphine.
Endocrinology 1986;118(6):2534-9.
1986: Arora R C; Meltzer H Y
Effect of adrenalectomy and corticosterone on [3H]imipramine binding in rat blood platelets and brain.
European journal of pharmacology 1986;123(3):415-9.
1986: Cohn J B; Wilcox C S; Meltzer H Y
Neuroendocrine effects of buspirone in patients with generalized anxiety disorder.
The American journal of medicine 1986;80(3B):36-40.
1986: Gudelsky G A; Passaro E; Meltzer H Y
Delayed activation of tuberoinfundibular dopamine neurons and suppression of prolactin secretion in the rat after morphine administration.
The Journal of pharmacology and experimental therapeutics 1986;236(3):641-5.
1986: Luchins D J; Meltzer H Y
A comparison of CT findings in acute and chronic ward schizophrenics.
Psychiatry research 1986;17(1):7-14.
1986: Andree T H; Mikuni M; Tong C Y; Koenig J I; Meltzer H Y
Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex.
Journal of neurochemistry 1986;46(1):191-7.
1986: Meltzer H Y; Arora R C
Platelet markers of suicidality.
Annals of the New York Academy of Sciences 1986;487():271-80.
1986: Gudelsky G A; Koenig J I; Jackman H; Meltzer H Y
Suppression of the hypo- and hyperthermic responses to 5-HT agonists following the repeated administration of monoamine oxidase inhibitors.
Psychopharmacology 1986;90(3):403-7.
1986: Koenig J I; Meltzer H Y; Gudelsky G A
Morphine or capsaicin administration alters the secretion of beta-endorphin into the hypophysial portal vasculature of the rat.
Neuroendocrinology 1986;43(5):611-7.
1986: Meltzer H Y; Nash J F; Koenig J I; Gudelsky G A
Clozapine: neuroendocrine studies of an atypical neuroleptic.
Clinical neuropharmacology 1986;9 Suppl 4():316-8.
1985: Gormley G J; Lowy M T; Reder A T; Hospelhorn V D; Antel J P; Meltzer H Y
Glucocorticoid receptors in depression: relationship to the dexamethasone suppression test.
The American journal of psychiatry 1985;142(11):1278-84.
1985: Moline R A; Singh S; Morris A; Meltzer H Y
Family expressed emotion and relapse in schizophrenia in 24 urban American patients.
The American journal of psychiatry 1985;142(9):1078-81.
1985: Luchins D J; Arora R C; Meltzer H Y
Platelet MAO in functional psychoses with evidence of brain atrophy.
The American journal of psychiatry 1985;142(8):996-7.
1985: Meltzer H Y; Simonovic M; Gudelsky G A
Phencyclidine-induced inhibition of rat prolactin secretion: increased portal blood dopamine.
European journal of pharmacology 1985;110(1):143-6.
1985: Lowy M T; Reder A T; Meltzer H Y
Hypercortisolism and depression.
The New England journal of medicine 1985;312(12):791-2.
1985: Gudelsky G A; Koenig J I; Meltzer H Y
Altered responses to serotonergic agents in Fawn-Hooded rats.
Pharmacology, biochemistry, and behavior 1985;22(3):489-92.
1985: Roos R P; Davis K; Meltzer H Y
Immunoglobulin studies in patients with psychiatric diseases.
Archives of general psychiatry 1985;42(2):124-8.
1985: Arora R C; Wunnicke V; Meltzer H Y
Effect of protein concentration on kinetic constants (Kd and Bmax) of 3H-imipramine binding in blood platelets.
Biological psychiatry 1985;20(1):116-9.
1985: Meltzer H Y
Long-term effects of neuroleptic drugs on the neuroendocrine system.
Advances in biochemical psychopharmacology 1985;40():59-68.
1984: Louie A K; Meltzer H Y
Lithium potentiation of antidepressant treatment.
Journal of clinical psychopharmacology 1984;4(6):316-21.
1984: Moretti R J; Hassan S Z; Goodman L I; Meltzer H Y
Comparison of ketamine and thiopental in healthy volunteers: effects on mental status, mood, and personality.
Anesthesia and analgesia 1984;63(12):1087-96.
1984: Arora R C; Kregel L; Meltzer H Y
Circadian rhythm of serotonin uptake in the blood platelets of normal controls.
Biological psychiatry 1984;19(11):1579-84.
1984: Lowy M T; Reder A T; Antel J P; Meltzer H Y
Glucocorticoid resistance in depression: the dexamethasone suppression test and lymphocyte sensitivity to dexamethasone.
The American journal of psychiatry 1984;141(11):1365-70.
1984: Meltzer H Y; Tong C; Luchins D J
Serum dopamine-beta-hydroxylase activity and lateral ventricular size in affective disorders and schizophrenia.
Biological psychiatry 1984;19(10):1395-402.
1984: Meltzer H Y; Luchins D J
Effect of clozapine in severe tardive dyskinesia: a case report.
Journal of clinical psychopharmacology 1984;4(5):286-7.
1984: Burbach D J; Lewine R; Meltzer H Y
Diagnostic concordance for schizophrenia as a function of sex.
Journal of consulting and clinical psychology 1984;52(3):478-9.
1984: Arora R C; Kregel L; Meltzer H Y
Seasonal variation of serotonin uptake in normal controls and depressed patients.
Biological psychiatry 1984;19(6):795-804.
1984: Lewine R J; Meltzer H Y
Negative symptoms and platelet monoamine oxidase activity in male schizophrenic patients.
Psychiatry research 1984;12(2):99-109.
1984: Goodnick P J; Arora R C; Jackman H; Meltzer H Y
Neurochemical changes during discontinuation of lithium prophylaxis. II. Alterations in platelet serotonin function.
Biological psychiatry 1984;19(6):891-8.
1984: Goodnick P J; Meltzer H Y
Neurochemical changes during discontinuation of lithium prophylaxis. I. Increases in clonidine-induced hypotension.
Biological psychiatry 1984;19(6):883-9.
1984: Luchins D J; Robertson A G; Meltzer H Y
Serum prolactin, psychopathology, and ventricular size in chronic schizophrenia.
Psychiatry research 1984;12(2):149-53.
1984: Meltzer H Y; Kolakowska T; Fang V S; Fogg L; Robertson A; Lewine R; Strahilevitz M; Busch D
Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms.
Archives of general psychiatry 1984;41(5):512-9.
1984: Fessler R G; Deyo S N; Meltzer H Y; Miller R J
Evidence that the medial and dorsal raphe nuclei mediate serotonergically-induced increases in prolactin release from the pituitary.
Brain research 1984;299(2):231-7.
1984: Meltzer H Y; Perline R; Tricou B J; Lowy M; Robertson A
Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. II. Relation to suicide, psychosis, and depressive symptoms.
Archives of general psychiatry 1984;41(4):379-87.
1984: Meltzer H Y; Umberkoman-Wiita B; Robertson A; Tricou B J; Lowy M; Perline R
Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania.
Archives of general psychiatry 1984;41(4):366-74.
1984: Meltzer H Y; Lowy M; Robertson A; Goodnick P; Perline R
Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate.
Archives of general psychiatry 1984;41(4):391-7.
1984: Robertson A G; Jackman H; Meltzer H Y
Prolactin response to morphine in depression.
Psychiatry research 1984;11(4):353-64.
1984: Grossman L S; Harrow M; Fudala J L; Meltzer H Y
The longitudinal course of schizoaffective disorders. A prospective follow-up study.
The Journal of nervous and mental disease 1984;172(3):140-9.
1984: Arora R C; Meltzer H Y
Imipramine binding in subpopulations of normal human blood platelets.
Biological psychiatry 1984;19(2):257-62.
1984: Mikuni M; Gudelsky G A; Simonovic M; Meltzer H Y
Interaction of (+)- and (-)-3-PPP with the dopamine receptor in the anterior pituitary gland.
Life sciences 1984;34(3):239-46.
1984: Mikuni M; Meltzer H Y
Reduction of serotonin-2 receptors in rat cerebral cortex after subchronic administration of imipramine, chlorpromazine, and the combination thereof.
Life sciences 1984;34(1):87-92.
1984: Lewine R; Burbach D; Meltzer H Y
Effect of diagnostic criteria on the ratio of male to female schizophrenic patients.
The American journal of psychiatry 1984;141(1):84-7.
1984: Gudelsky G A; Meltzer H Y
Function of tuberoinfundibular dopamine neurons in pargyline- and reserpine-treated rats.
Neuroendocrinology 1984;38(1):51-5.
1984: Luchins D J; Lewine R R; Meltzer H Y
Lateral ventricular size, psychopathology, and medication response in the psychoses.
Biological psychiatry 1984;19(1):29-44.
1984: Meltzer H Y
Schizoaffective disorder: is the news of its nonexistence premature? Editor's introduction.
Schizophrenia bulletin 1984;10(1):11-3.
1984: Meltzer H Y; Arora R C; Metz J
Biological studies of schizoaffective disorders.
Schizophrenia bulletin 1984;10(1):49-70.
1984: Meltzer H Y
Serotonergic function in the affective disorders: the effect of antidepressants and lithium on the 5-hydroxytryptophan-induced increase in serum cortisol.
Annals of the New York Academy of Sciences 1984;430():115-37.
1984: Simonovic M; Gudelsky G A; Meltzer H Y
Effect of 8-hydroxy-2-(di-n-propylamino) tetralin on rat prolactin secretion.
Journal of neural transmission 1984;59(2):143-9.
1984: Andree T H; Mikuni M; Meltzer H Y
Effect of subchronic treatment with neuroleptic, imipramine, and the combination on serotonin receptor binding in rat cerebral cortex.
Psychopharmacology bulletin 1984;20(3):349-53.
1984: Goodnick P J; Meltzer H Y
Treatment of schizoaffective disorders.
Schizophrenia bulletin 1984;10(1):30-48.
1984: Gudelsky G A; Simonovic M; Meltzer H Y
Dopaminergic and serotonergic control of neuroendocrine function.
Monographs in neural sciences 1984;10():85-102.
1983: Meltzer H Y; Uberkoman-Wiita B; Robertson A; Tricou B J; Lowy M
Enhanced serum cortisol response to 5-hydroxytryptophan in depression and mania.
Life sciences 1983;33(25):2541-9.
1983: Goodnick P J; Tong C; Duncavage M B; Meltzer H Y
Neuroleptic-induced reductions in serum dopamine-beta-hydroxylase in schizophrenia.
Biological psychiatry 1983;18(12):1485-8.
1983: Young M A; Abrams R; Taylor M A; Meltzer H Y
Establishing diagnostic criteria for mania.
The Journal of nervous and mental disease 1983;171(11):676-82.
1983: Luchins D J; Meltzer H Y
Ventricular size and psychosis in affective disorder.
Biological psychiatry 1983;18(10):1197-8.
1983: Meltzer H Y; Tricou B J; Robertson A; Lowy M
Hormone response to 5-HTP.
Psychiatry research 1983;10(2):151-2.
1983: Luchins D J; Meltzer H Y
A blind, controlled study of occipital cerebral asymmetry in schizophrenia.
Psychiatry research 1983;10(2):87-95.
1983: Meltzer H Y; Flemming R; Robertson A
The effect of buspirone on prolactin and growth hormone secretion in man.
Archives of general psychiatry 1983;40(10):1099-102.
1983: Arora R C; Tong C; Jackman H L; Stoff D; Meltzer H Y
Serotonin uptake and imipramine binding in blood platelets and brain of Fawn-hooded and Sprague Dawley rats.
Life sciences 1983;33(5):437-42.
1983: Jackman H L; Meltzer H Y
Kinetic constants of platelet monoamine oxidase in schizophrenia.
The American journal of psychiatry 1983;140(8):1044-7.
1983: Meltzer H Y; Simonovic M; Gudelsky G A
Effects of pirenperone and ketanserin on rat prolactin secretion in vivo and in vitro.
European journal of pharmacology 1983;92(1-2):83-9.
1983: Simonovic M; Meltzer H Y
Biphasic effect of 5-methoxy-N,N-dimethyltryptamine on rat prolactin secretion.
Brain research 1983;272(2):269-75.
1983: Jackman H; Luchins D; Meltzer H Y
Platelet serotonin levels in schizophrenia: relationship to race and psychopathology.
Biological psychiatry 1983;18(8):887-902.
1983: Meltzer H Y; Busch D
Serum prolactin response to chlorpromazine and psychopathology in schizophrenics: implications for the dopamine hypothesis.
Psychiatry research 1983;9(4):285-99.
1983: Meltzer H Y; Busch D A; Fang V S
Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response.
Psychiatry research 1983;9(4):271-83.
1983: Goodnick P J; Meltzer H Y
Effect of subchronic lithium treatment on apomorphine-induced change in prolactin and growth hormone secretion.
Journal of clinical psychopharmacology 1983;3(4):239-43.
1983: Meltzer H Y; Arora R C; Goodnick P
Effect of lithium carbonate on serotonin uptake in blood platelets of patients with affective disorders.
Journal of affective disorders 1983;5(3):215-21.
1983: Gudelsky G A; Passaro E; Meltzer H Y
Effect of two dopamine agonists, TL-99 and 3-PPP, on prolactin secretion in the rat.
European journal of pharmacology 1983;90(4):423-5.
1983: Meltzer H Y; Simonovic M; So R
Effects of a series of substituted benzamides on rat prolactin secretion and 3H-spiperone binding to bovine anterior pituitary membranes.
Life sciences 1983;32(25):2877-86.
1983: Luchins D J; Jackman H; Meltzer H Y
Lateral ventricular size and drug-induced Parkinsonism.
Psychiatry research 1983;9(1):9-16.
1983: Arora R C; Meltzer H Y
Effects of amoxapine on serotonin uptake in human blood platelets of depressed patients and normal controls.
Psychiatry research 1983;9(1):29-36.
1983: Arora R C; Meltzer H Y
Effects of chlorpromazine on serotonin uptake in blood platelets.
Psychiatry research 1983;9(1):23-8.
1983: Meltzer H Y; Fang V S
Cortisol determination and the dexamethasone suppression test. A review.
Archives of general psychiatry 1983;40(5):501-5.
1983: Mikuni M; Stoff D M; Meltzer H Y
Effects of combined administration of imipramine and chlorpromazine on beta- and alpha 2-adrenergic receptors in rat cerebral cortex.
European journal of pharmacology 1983;89(3-4):313-6.
1983: Meltzer H Y; Mikuni M; Simonovic M; Gudelsky G A
Effect of a novel benzamide, YM-09151-2, on rat serum prolactin levels.
Life sciences 1983;32(9):1015-21.
1983: Arora R C; Sahai S; Meltzer H Y
Correlation between MAO activity in blood platelets obtained by single and multiple centrifugations.
Psychiatry research 1983;8(2):147-51.
1983: Ross-Canada J; Chizzonite R A; Meltzer H Y
Retention of sarcoplasmic calcium inhibits development of the phencyclidine-restraint experimental myopathy.
Experimental neurology 1983;79(1):1-10.
1983: Meltzer H Y; Luchins D J
Platelet MAO and family history of schizophrenia: method and madness.
Psychiatry research 1983;8(1):83-5.
1983: Meltzer H Y; Arora R C; Tricou B J; Fang V S
Serotonin uptake in blood platelets and the dexamethasone suppression test in depressed patients.
Psychiatry research 1983;8(1):41-7.
1983: Meltzer H Y; Simonovic M; Gudelsky G A
Effect of yohimbine on rat prolactin secretion.
The Journal of pharmacology and experimental therapeutics 1983;224(1):21-7.
1983: Luchins D J; Lewine R R; Meltzer H Y
Lateral ventricular size in the psychoses: relation to psychopathology and therapeutic and adverse response to medications.
Psychopharmacology bulletin 1983;19(3):518-22.
1983: Lewine R R; Fogg L; Meltzer H Y
Assessment of negative and positive symptoms in schizophrenia.
Schizophrenia bulletin 1983;9(3):368-76.
1983: Meltzer H Y; Kolakowska T; Robertson A; Tricou B J
Effect of low-dose bromocriptine in treatment of psychosis: the dopamine autoreceptor-stimulation strategy.
Psychopharmacology 1983;81(1):37-41.
1983: Arora R C; Fessler R G; Meltzer H Y
Effects of lithium carbonate on serotonin uptake in rat blood platelets.
Progress in neuro-psychopharmacology & biological psychiatry 1983;7(1):39-45.
1983: Brockington I F; Meltzer H Y
The nosology of schizoaffective psychosis.
Psychiatric developments 1983;1(4):317-38.
1982: Brockington I F; Altman E; Hillier V; Meltzer H Y; Nand S
The clinical picture of bipolar affective disorder in its depressed phase. A report from London and Chicago.
The British journal of psychiatry : the journal of mental science 1982;141():558-62.
1982: Matuzas W; Meltzer H Y; Uhlenhuth E H; Glass R M; Tong C
Plasma dopamine-beta-hydroxylase in depressed patients.
Biological psychiatry 1982;17(12):1415-24.
1982: Daiguji M; Meltzer H Y
Effect of chronic phencyclidine or d-amphetamine treatment on [3H]spiroperidol binding in rat caudate-putamen and nucleus accumbens.
European journal of pharmacology 1982;85(3-4):339-42.
1982: Meltzer H Y; Perline R; Lewine R
Biological studies of DSM-III psychotic disorders. I. Platelet measures and apomorphine-induced growth hormone response.
The Journal of nervous and mental disease 1982;170(12):758-65.
1982: Meltzer H Y; Fleming R
Effect of buspirone on prolactin and growth hormone secretion in laboratory rodents and man.
The Journal of clinical psychiatry 1982;43(12 Pt 2):76-9.
1982: Brockington I F; Perris C; Meltzer H Y
Cycloid psychoses: diagnosis and heuristic value.
The Journal of nervous and mental disease 1982;170(11):651-6.
1982: Arora R C; Meltzer H Y
Serotonin uptake in subpopulations of normal human blood platelets.
Biological psychiatry 1982;17(10):1157-62.
1982: Robertson A G; Tricou B J; Fang V S; Meltzer H Y
Biological markers for depressive illness.
Psychopharmacology bulletin 1982;18(4):120-2.
1982: Meltzer H Y; Duncavage M B; Jackman H; Arora R C; Tricou B J; Young M
Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients.
The American journal of psychiatry 1982;139(10):1242-8.
1982: Nasr S J; Altman E; Pscheidt G; Meltzer H Y
Glucose-6-phosphate dehydrogenase deficiency in a psychiatric population: a preliminary study.
Biological psychiatry 1982;17(8):925-8.
1982: Young M A; Tanner M A; Meltzer H Y
Operational definitions of schizophrenia: what do they identify?
The Journal of nervous and mental disease 1982;170(8):443-7.
1982: Duncavage M; Luchins D J; Meltzer H Y
Platelet MAO activity and family history of schizophrenia.
Psychiatry research 1982;7(1):47-51.
1982: Bowers M B; Meltzer H Y; Heninger G R
Correlation of plasma and CSF prolactin with CSF GABA during neuroleptic treatment.
Life sciences 1982;31(1):59-65.
1982: Meltzer H Y; Fang V S; Tricou B J; Robertson A; Piyaka S K
Effect of dexamethasone on plasma prolactin and cortisol levels in psychiatric patients.
The American journal of psychiatry 1982;139(6):763-8.
1982: Arora R C; Meltzer H Y
Serotonin uptake by blood platelets of schizophrenic patients.
Psychiatry research 1982;6(3):327-33.
1982: Meltzer H Y; Busch D A; Tricou B J; Robertson A
Effect of (Des-Tyr)-gamma-endorphin in schizophrenia.
Psychiatry research 1982;6(3):313-26.
1982: Harrow M; Grossman L S; Silverstein M L; Meltzer H Y
Thought pathology in manic and schizophrenic patients. Its occurrence at hospital admission and seven weeks later.
Archives of general psychiatry 1982;39(6):665-71.
1982: Fang V S; Meltzer H Y
ACTH levels after the dexamethasone suppression test in depression.
The New England journal of medicine 1982;306(21):1296-7.
1982: Meltzer H Y; Tueting P; Jackman H
The effect of lithium on platelet monoamine oxidase activity in bipolar and schizoaffective disorders.
The British journal of psychiatry : the journal of mental science 1982;140():192-8.
1982: Meltzer H Y; Fang V S; Tricou B J
Dexamethasone and prolactin in depression.
Archives of general psychiatry 1982;39(2):236.
1982: Baron M; Perlman R; Levitt M; Meltzer H; Gruen R; Asnis L
Plasma copper and dopamine-beta-hydroxylase in schizophrenia.
Biological psychiatry 1982;17(1):115-20.
1982: Brockington I F; Meltzer H Y
Documenting an episode of psychiatric illness: need for multiple information sources, multiple raters, and narrative.
Schizophrenia bulletin 1982;8(3):485-92.
1982: Meltzer H Y; Liberman R P
What is schizophrenia?
Schizophrenia bulletin 1982;8(3):433-7.
1982: Metz J; Busch D A; Meltzer H Y
Clinical, electrophysiological, and biochemical effects of des-tyrosine-gamma-endorphin in psychiatric patients.
Annals of the New York Academy of Sciences 1982;398():496-508.
1982: Fessler R G; Sturgeon R D; London S F; Meltzer H Y
Effects of lithium on behaviour induced by phencyclidine and amphetamine in rats.
Psychopharmacology 1982;78(4):373-6.
1982: Metz J; Holcomb H H; Meltzer H Y
Effect of chlorpromazine on H-reflex recovery curves in normal subjects and schizophrenic patients.
Psychopharmacology 1982;78(4):342-5.
1982: Robertson A G; Berry R; Meltzer H Y
Prolactin stimulating effects of amoxapine and loxapine in psychiatric patients.
Psychopharmacology 1982;78(3):287-92.
1982: Sturgeon R D; Fessler R G; London S F; Meltzer H Y
Behavioral effects of chronic phencyclidine administration in rats.
Psychopharmacology 1982;76(1):52-6.
1982: Meltzer H Y; So R; Fang V S
Effect of benzamide drugs on prolactin secretion: relation to the dopamine receptor.
Advances in biochemical psychopharmacology 1982;35():61-82.
1982: Meltzer H Y; Wiita B; Tricou B J; Simonovic M; Fang V; Manov G
Effect of serotonin precursors and serotonin agonists on plasma hormone levels.
Advances in biochemical psychopharmacology 1982;34():117-39.
1982: Meltzer H Y
Dopamine autoreceptor stimulation: clinical significance.
Pharmacology, biochemistry, and behavior 1982;17 Suppl 1():1-10.
1982: Meltzer H Y; Simonovic M; Fang V S; Gudelsky G A
Effect of buspirone on rat plasma prolactin levels and striatal dopamine turnover.
Psychopharmacology 1982;78(1):49-53.
1982: Meltzer H Y; Fang V S; Tricou B J; Robertson A
Effect of antidepressants on neuroendocrine axis in humans.
Advances in biochemical psychopharmacology 1982;32():303-16.
1981: Meltzer H Y; Arora R C; Baber R; Tricou B J
Serotonin uptake in blood platelets of psychiatric patients.
Archives of general psychiatry 1981;38(12):1322-6.
1981: Sahai S; Arora R C; Meltzer H Y
Platelet monoamine oxidase. I: Effect of temperature, anticoagulant, and centrifugation technique.
Biological psychiatry 1981;16(11):1077-83.
1981: Daiguji M; Meltzer H Y; Tong C; U'Prichard D C; Young M; Kravitz H
alpha 2-Adrenergic receptors in platelet membranes of depressed patients: no change in number of 3H-yohimbine affinity.
Life sciences 1981;29(20):2059-64.
1981: Sturgeon R D; Fessler R G; London S F; Meltzer H Y
A comparison of the effects of neuroleptics on phencyclidine-induced behaviors in the rat.
European journal of pharmacology 1981;76(1):37-53.
1981: Meltzer H Y; Busch D A; Schyve P M; Fang V S
Effect of (des-Tyr1)-gamma-endorphin on prolactin secretion.
Archives of general psychiatry 1981;38(10):1183.
1981: Ross-Stanton J; Meltzer H Y
Motor neuron branching patterns in psychotic patients.
Archives of general psychiatry 1981;38(10):1097-103.
1981: Sahai S; Arora R C; Meltzer H Y
Effect of chlorpromazine treatment on monoamine oxidase activity in platelets isolated by the Corash method.
Psychiatry research 1981;5(2):111-4.
1981: Nasr S; Altman E G; Meltzer H Y
Concordance of atopic and affective disorders.
Journal of affective disorders 1981;3(3):291-6.
1981: Meltzer H Y
Prolactin and psychiatry.
The American journal of psychiatry 1981;138(9):1203-6.
1981: Meltzer H Y; Busch D A; Creese I R; Snyder S H; Fang V S
Effect of intramuscular chlorpromazine on serum prolactin levels in schizophrenic patients and normal controls.
Psychiatry research 1981;5(1):95-105.
1981: Fang V S; Tricou B J; Robertson A; Meltzer H Y
Plasma ACTH and cortisol levels in depressed patients: relation to dexamethasone suppression test.
Life sciences 1981;29(9):931-8.
1981: Goode D J; Meltzer H Y; Fang V S
Daytime variation in serum prolactin level in patients receiving oral and depot antipsychotic medication.
Biological psychiatry 1981;16(7):653-62.
1981: Meltzer H Y; Simonovic M
Effect of 3-PPP, a putative dopamine autoreceptor agonist, on rat serum prolactin levels.
Life sciences 1981;29(1):99-105.
1981: Daiguji M; Meltzer H Y; U'Prichard D C
Human platelet alpha 2-adrenergic receptors: labeling with 3H-yohimbine, a selective antagonist ligand.
Life sciences 1981;28(24):2705-17.
1981: Arora R C; Meltzer H Y
A modified assay method for determining serotonin uptake in human platelets.
Clinica chimica acta; international journal of clinical chemistry 1981;112(2):225-33.
1981: Metz J; Busch D A; Meltzer H Y
Des-tyrosine-gamma-endorphin: H-reflex response similar to neuroleptics.
Life sciences 1981;28(18):2003-8.
1981: Meltzer H Y; Busch D; Fang V S
Hormones, dopamine receptors and schizophrenia.
Psychoneuroendocrinology 1981;6(1):17-36.
1981: Meltzer H Y; Simonovic M; Sturgeon R D; Fang V S
Effect of antidepressants, lithium and electroconvulsive treatment on rat serum prolactin levels.
Acta psychiatrica Scandinavica. Supplementum 1981;290():100-21.
1980: Fessler R G; Sturgeon R D; Meltzer H Y
Effects of phencyclidine and methylphenidate on d-amphetamine-induced behaviors in reserpine pretreated rats.
Pharmacology, biochemistry, and behavior 1980;13(6):835-42.
1980: Goode D J; Meltzer H Y; Fang V S
Increased serum prolactin levels during phenothiazine and butyrophenone treatment of six postpartum women.
Psychoneuroendocrinology 1980;5(4):345-51.
1980: Meltzer H Y; Sturgeon R D; Simonovic M; Fessler R G
Phencyclidine as an indirect dopamine agonist [proceedings]
Psychopharmacology bulletin 1980;16(4):62-5.
1980: Arora R C; Meltzer H Y
Lithium and serotonin uptake by platelets.
The British journal of psychiatry : the journal of mental science 1980;137():396-7.
1980: Arora R C; Meltzer H Y
In vitro effect of phencyclidine and other psychomotor stimulants on serotonin uptake in human platelets.
Life sciences 1980;27(17):1607-13.
1980: Meltzer H Y; Nasr S J; Tong C
Serum dopamine-beta-hydroxylase activity in schizophrenia.
Biological psychiatry 1980;15(5):781-8.
1980: Ross-Stanton J; Schlessinger S; Meltzer H Y
Multiple neuromuscular abnormalities in a paranoid schizophrenic.
Psychiatry research 1980;3(1):53-67.
1980: Metz J; Goode D J; Meltzer H Y
Descriptive studies of H-reflex recovery curves in psychiatric patients.
Psychological medicine 1980;10(3):541-8.
1980: Huang C C; Friedman A M; So R; Simonovic M; Meltzer H Y
Synthesis and biological evaluation of p-bromospiperone as potential neuroleptic drug.
Journal of pharmaceutical sciences 1980;69(8):984-6.
1980: Doherty J D; Simonovic M; So R; Meltzer H Y
The effect of phencyclidine on dopamine synthesis and metabolic in rat striatum.
European journal of pharmacology 1980;65(2-3):139-49.
1980: Kaskey G B; Nasr S; Meltzer H Y
Drug treatment in delusional depression.
Psychiatry research 1980;2(3):267-77.
1980: Meltzer H Y; Fang V S; Young M A
Clozapine-like drugs.
Psychopharmacology bulletin 1980;16(3):32-5.
1980: Meltzer H Y; Ross-Stanton J; Schlessinger S
Mean serum creatine kinase activity in patients with functional psychoses.
Archives of general psychiatry 1980;37(6):650-5.
1980: Meltzer H Y; Arora R C; Babar R; Jackman H; Nasr S; Pscheidt G; Smith M; Strahilevitz M
Platelet monoamine oxidase activity and schizophrenia.
Archives of general psychiatry 1980;37(3):357.
1980: Meltzer H Y; Arora R C
Skeletal muscle MAO activity in the major psychoses. Relationship with platelet and plasma MAO activities.
Archives of general psychiatry 1980;37(3):333-9.
1980: Arora R C; Meltzer H Y
Muscle cholinesterase: effect of phencyclidine and ketamine on rat and human muscle cholinesterase activity.
Experimental neurology 1980;67(1):1-10.
1980: Young M A; Meltzer H Y
RMI-81,582, a novel antipsychotic drug.
Psychopharmacology 1980;67(1):101-6.
1980: Meltzer H Y; Arora R C; Jackman H; Pscheidt G; Smith M D
Platelet monoamine oxidase and plasma amine oxidase in psychiatric patients.
Schizophrenia bulletin 1980;6(2):213-9.
1980: Jackman H L; Meltzer H Y
Human platelet monoamine oxidase activity and in vivo manipulation of plasma glucose concentration.
Communications in psychopharmacology 1980;4(5):335-8.
1980: Nasr S; Daiguji M; Tong C; Meltzer H Y
Comparison of midday serum dopamine-beta-hydroxylase activity in depressed patients and normal controls.
Communications in psychopharmacology 1980;4(4):263-7.
1980: Bowers M B; Heninger G R; Sternberg D; Meltzer H Y
Clinical processes and central dopaminergic activity in psychotic disorders.
Communications in psychopharmacology 1980;4(3):177-83.
1980: Meltzer H Y
Relevance of dopamine autoreceptors for psychiatry: preclinical and clinical studies.
Schizophrenia bulletin 1980;6(3):456-75.
1980: Jackman H L; Meltzer H Y
Factors affecting determination of platelet monoamine oxidase activity.
Schizophrenia bulletin 1980;6(2):259-66.
1980: Meltzer H Y; Jackman H; Arora R C
Brain and skeletal muscle monoamine oxidase activity in schizophrenia.
Schizophrenia bulletin 1980;6(2):208-12.
1980: Young M A; Meltzer H Y
The relationship of demographic, clinical, and outcome variables to neuroleptic treatment requirements.
Schizophrenia bulletin 1980;6(1):88-101.
1980: Mosher L R; Meltzer H Y
Drugs and psychosocial treatment: editors' introduction.
Schizophrenia bulletin 1980;6(1):8-9.
1979: Meltzer H Y; Goode D J; Schyve P M; Young M; Fang V S
Effect of clozapine on human serum prolactin levels.
The American journal of psychiatry 1979;136(12):1550-5.
1979: Sturgeon R D; Fessler R G; Meltzer H Y
Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats.
European journal of pharmacology 1979;59(3-4):169-79.
1979: Meltzer H Y; Arora R C
Distribution of type A and type B monoamine oxidase activities in rat and chicken skeletal muscle and nerves.
Biochemical pharmacology 1979;28(22):3261-4.
1979: Simonovic M; Meltzer H Y
Repeated administration of 5-methoxy-N,N-dimethyltryptamine to male rats potentiates stimulation of prolactin secretion by serotonin agonists.
European journal of pharmacology 1979;58(4):399-405.
1979: Crayton J W; Meltzer H Y
Degeneration and regeneration of motor neurons in psychotic patients.
Biological psychiatry 1979;14(5):803-19.
1979: Busch D A; Fang V S; Meltzer H Y
Serum prolactin levels following intramuscular chlorpromazine: two- and three-hour response as predictors of six-hour response.
Psychiatry research 1979;1(2):153-9.
1979: Prange A J; Loosen P T; Wilson I C; Meltzer H Y; Fang V S
Behavioral and endocrine responses of schizophrenic patients to TRH (protirelin).
Archives of general psychiatry 1979;36(10):1086-93.
1979: Meltzer H Y; So R
Effect of morphine, beta-endorphin and leu-enkephalin on 3H-spiroperidol binding to bovine pituitary membranes.
Life sciences 1979;25(6):531-5.
1979: Jackman H; Arora R; Meltzer H Y
Comparison of platelet count and platelet protein methods for determination of platelet MAO activity.
Clinica chimica acta; international journal of clinical chemistry 1979;96(1-2):15-23.
1979: Meltzer H Y; So R; Miller R J; Fang V S
Comparison of the effects of substituted benzamides and standard neuroleptics on the binding of 3H-spiroperidol in the rat pituitary and striatum with in vivo effects on rat prolactin secretion.
Life sciences 1979;25(7):573-83.
1979: Kuncl R W; Meltzer H Y
Beta adrenergic-mediated myofibrillar disruption and enzyme efflux in an experimental myopathy related to isometric muscle activity.
Experimental and molecular pathology 1979;31(1):113-23.
1979: Goode D J; Meltzer H Y; Moretti R; Kupfer D J; McPartland R J
The relationship between wrist-monitored motor activity and serum CPK activity in psychiatric in-patients.
The British journal of psychiatry : the journal of mental science 1979;135():62-6.
1979: West A P; Meltzer H Y
Paradoxical lithium neurotoxicity: a report of five cases and a hypothesis about risk for neurotoxicity.
The American journal of psychiatry 1979;136(7):963-6.
1979: Ross-Stanton J; Meltzer H Y
Skeletal muscle morphology of depressed patients after medication.
Muscle & nerve 1979;2(3):239-40.
1979: Fessler R G; Sturgeon R D; Meltzer H Y
Phencyclidine-induced ipsilateral rotation in rats with unilateral 6-hydroxydopamine-induced lesions of the substantia nigra.
Life sciences 1979;24(14):1281-8.
1979: Meltzer H Y; Fessler R G; Simonovic M; Doherty J; Fang V S
Effect of d- and l-amphetamine on rat plasma prolactin levels.
Psychopharmacology 1979;61(1):63-9.
1979: Meltzer H Y; Fessler R G; Simonovic M; Sturgeon D
PCP: neurochemistry, treatment, and more.
The American journal of psychiatry 1979;136(2):235-7.
1979: Kuncl R W; Meltzer H Y
Lesions of the myofibril in myopathic and normal tissue from seven striated muscles. Experimental myopathy of isometric activity produced by phencyclidine and restraint.
Acta neuropathologica 1979;45(2):83-95.
1979: Goode D J; Meltzer H Y; Mazura T A
Hoffmann reflex abnormalities in psychotic patients.
Biological psychiatry 1979;14(1):95-110.
1979: Cho H W; Meltzer H Y
Factors affecting stability of isozymes of creatine phosphokinase.
American journal of clinical pathology 1979;71(1):75-82.
1979: Meltzer H Y; Goode D J; Arora R C
Neuromuscular dysfunction and vulnerability to psychosis.
Psychopharmacology bulletin 1979;15(1):43-4.
1979: Holzman P S; Meltzer H Y; Kringlen E; Levy D L; Haberman S J; Davis J M
Plasma CPK levels in monozygotic and dizygotic twins discordant for schizophrenia.
Journal of psychiatric research 1979;15(2):127-31.
1979: Meltzer H Y; Young M; Metz J; Fang V S; Schyve P M; Arora R C
Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant.
Journal of neural transmission 1979;45(2):165-75.
1979: Meltzer H Y
Clinical evidence for multiple dopamine receptors in man.
Communications in psychopharmacology 1979;3(6):457-70.
1979: Meltzer H Y
Biology of schizophrenia subtypes: a review and proposal for method of study.
Schizophrenia bulletin 1979;5(3):460-79.
1978: Meltzer H Y
Creatine phosphokinase activity in blacks vs whites.
Archives of internal medicine 1978;138(11):1750.
1978: Schyve P M; Smithline F; Meltzer H Y
Neuroleptic-induced prolactin level elevation and breast cancer: an emerging clinical issue.
Archives of general psychiatry 1978;35(11):1291-1301.
1978: Meltzer H Y; Simonovic M; Fessler R G
Neuropharmacological studies of prolactin secretion.
Psychopharmacology bulletin 1978;14(4):26-9.
1978: Meltzer H Y; Stanisic D; Simonovic M; Fang V S
Ketamine as an anesthetic for obtaining plasma for rat prolactin assays.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1978;159(1):12-5.
1978: Meltzer H Y; Fessler R G; Simonovic M; Fang V S
The effect of mescaline, 3, 4-dimethoxyphenethylamine and 2, 5-dimethoxy-4-methylamphetamine on rat plasma prolactin: evidence for serotonergic mediation.
Life sciences 1978;23(11):1185-92.
1978: Meltzer H Y; Simonovic M; Fang V; Piyakalamala S; Young M
A comparison of the effects of anti-psychotic drugs on pituitary, striatal and limbic system post-synaptic dopamine receptors.
Life sciences 1978;23(6):605-9.
1978: Meltzer H Y; Miller R J; Fessler R G; Simonovic M; Fang V S
Effects of enkephalin in analogues on prolactin release in the rat.
Life sciences 1978;22(21):1931-7.
1978: Meltzer H Y
Mechanisms of antipsychotic effect in treatment of acute schizophrenia.
Lancet 1978;1(8074):1151-2.
1978: Stahl S M; Meltzer H Y
A kinetic and pharmacologic analysis of 5-hydroxytryptamine transport by human platelets and platelet storage granules: comparison with central serotonergic neurons.
The Journal of pharmacology and experimental therapeutics 1978;205(1):118-32.
1978: Meltzer H Y; Dorus E; Grunhaus L; Davis J M; Belmaker R
Genetic control of human plasma creatine phosphokinase activity.
Clinical genetics 1978;13(4):321-6.
1978: Meltzer H Y; Fessler R G; Simonovic M; Fang V S
Stimulation of rat prolactin secretion by indolealkylamine hallucinogens.
Psychopharmacology 1978;56(3):255-9.
1978: Stahl S M; Meltzer H Y
The human platelet as a model for the dopaminergic neuron: kinetic and pharmacologic properties and the role of amine storage granules.
Experimental neurology 1978;59(1):1-15.
1978: Meltzer H Y; Fang V S; Goode D J
Prolactin and neuroleptics: clinical implications for efficacy and toxicity. The effect of neuroleptics and alpha-methyl-para-tyrosine on serum prolactin levels in laboratory animals and man.
Psychopharmacology bulletin 1978;14(1):5-7.
1978: Schyve P M; Smithline F; Meltzer H Y
Prolactin and breast cancer.
Psychopharmacology bulletin 1978;14(1):17-9.
1978: Fang V S; Cho H W; Meltzer H Y
Enzymic, electrophoretic and immunoreactive properties of labeled MM and BB isoenzymes of human creatine kinase.
Enzyme 1978;23(3):210-4.
1978: Meltzer H Y; Fessler R G; Fang V S
Effect of piperoxane on rat plasma prolactin.
Communications in psychopharmacology 1978;2(3):237-42.
1978: Meltzer H Y; Simonovic M; Fang V S
The effect of muscimol on prolactin secretion in male rats.
Communications in psychopharmacology 1978;2(3):231-6.
1978: Fang V S; Ho B T; Meltzer H Y
Effect of 6-methoxy-tetrahydro-beta-carboline on serum prolactin levels of male rats.
Communications in psychopharmacology 1978;2(1):59-63.
1978: Ziemba T; Meltzer H Y; Davis J M
Do anticholinergic antagonize antipsychotic drug action?
Schizophrenia bulletin 1978;4(1):7-12.
1977: Goode D J; Weinberg D H; Mazura T A; Curtiss G; Moretti R J; Meltzer H Y
Effect of limb restraints on serum creatine phosphokinase activity in normal volunteers.
Biological psychiatry 1977;12(6):743-55.
1977: Kuncl R W; Meltzer H Y
Role of the adrenal in an experimental myopathy.
Experimental neurology 1977;57(2):322-30.
1977: Fang V S; Cho H W; Meltzer H Y
Radioimmunoassay for MM and BB isoenzymes of creatine kinase substantiated by clinical application.
Clinical chemistry 1977;23(10):1898-902.
1977: Meltzer H Y; Fessler R G; Fang V S
Perlapine: relationship between stimulation of prolactin secretion and antipsychotic activity.
Psychopharmacology 1977;54(2):183-6.
1977: Smith R C; Meltzer H Y; Arora R C; Davis J M
Effects of phencyclidine on [3H]catecholamine and [3H]serotonin uptake in synaptosomal preparations from rat brain.
Biochemical pharmacology 1977;26(15):1435-9.
1977: Crayton J W; Meltzer H Y; Goode D J
Motoneuron excitability in psychiatric patients.
Biological psychiatry 1977;12(4):545-61.
1977: Meltzer H Y; Fessler R G; Simonovic M; Doherty J; Fang V S
Lysergic acid diethylamide: evidence for stimulation of pituitary dopamine receptors.
Psychopharmacology 1977;54(1):39-44.
1977: Arora R C; Meltzer H Y
Isoenzymes of manoamine oxidase in human skeletal muscle.
Experimental neurology 1977;55(2):318-26.
1977: Meltzer H Y; Fang V S
Effect of gamma-butyrolactone and baclofen on plasma prolactin in male rats.
Biochemical pharmacology 1977;26(7):645-6.
1977: Cho H W; Prilipko L; Meltzer H Y; Keller C
Isoenzymes of creatine phosphokinase in white blood cells.
Experientia 1977;33(2):166-7.
1977: Meltzer H Y; Fang V S; Simonovich M; Paul S M
Effect of metabolites of chlorpromazine on plasma prolactin levels in male rats.
European journal of pharmacology 1977;41(4):431-6.
1977: Meltzer H Y; Goode D J; Fang V S
Effects of chlorpromazine on plasma prolactin and chlorpromazine levels [proceedings].
Psychopharmacology bulletin 1977;13(1):59-60.
1977: Stahl S M; Meltzer H Y
Serotonin accumulation by skeletal muscle.
Experimental neurology 1977;54(1):42-53.
1977: Meltzer H Y; Piyakalmala S; Schyve P; Fang V S
Lack of effect of tricyclic antidepressants on serum prolactin levels.
Psychopharmacology 1977;51(2):185-7.
1977: Meltzer H Y; Paul S M; Fang V S
Effect of flupenthixol and butaclamol isomers on prolactin secretion in rats.
Psychopharmacology 1977;51(2):181-3.
1977: Arora R C; Meltzer H Y
Characterization of rat skeletal muscle monoamine oxidase.
Biochemical pharmacology 1977;26(1):45-9.
1977: Goode D J; Meltzer H Y; Crayton J W; Mazura T A
Physiologic abnormalities of the neuromuscular system in schizophrenia.
Schizophrenia bulletin 1977;3(1):121-38.
1976: Crayton J W; Meltzer H Y
Motor endplate alterations in schizophrenic patients.
Nature 1976;264(5587):658-9.
1976: Cho H W; Meltzer H Y; Joung J I; Goode D
Effect of incubation in human plasma on electrophoretic mobility of brain-type creatine phosphokinase.
Clinica chimica acta; international journal of clinical chemistry 1976;73(2):257-65.
1976: Finnegan K T; Kanner M I; Meltzer H Y
Phencyclidine-induced rotational behavior in rats with nigrostriatal lesions and its modulation by dopaminergic and cholinergic agents.
Pharmacology, biochemistry, and behavior 1976;5(6):651-60.
1976: Meltzer H Y; Hassan S Z; Russo P; Cho H W
Isoenzymes of creatine phosphokinase in serum of families with malignant hyperpyrexia.
Anesthesia and analgesia 1976;55(6):797-9.
1976: Meltzer H Y
Creatine phosphokinase activity in blacks.
Archives of internal medicine 1976;136(11):1336.
1976: Meltzer H Y; Goode D J; Fang V S; Schyve P; Young M
Dopamine and schizophrenia.
Lancet 1976;2(7995):1142.
1976: Meltzer H Y; Fang V S; Paul S M; Kaluskar R
Effect of quipazine on rat plasma prolactin levels.
Life sciences 1976;19(7):1073-8.
1976: Goode D J; Meltzer H Y
Effects of isometric exercise on serum creatine phosphokinase activity.
Archives of general psychiatry 1976;33(10):1207-11.
1976: Meltzer H Y
Dopamine receptors and average clinical doses.
Science (New York, N.Y.) 1976;194(4264):545-6.
1976: Meltzer H Y; Kuncl R W; Yang V
Incidence of Z band streaming and myofibrillar disruptions in skeletal muscle from healthy young people.
Neurology 1976;26(9):853-7.
1976: Meltzer H Y; Rastogi S; Ellison J
Quantitative histochemical evaluation of normal human skeletal muscle.
Neurology 1976;26(9):849-52.
1976: Arora R C; Meltzer H Y
In vitro and in vivo inhibition of rat liver, brain and muscle monoamine oxidase by chlorpromazine and imipramine.
Research communications in chemical pathology and pharmacology 1976;14(4):755-8.
1976: Pscheidt G R; Meltzer H Y
Siliconising agent inhibits platelet M.A.O.
Lancet 1976;1(7982):474.
1976: Crayton J W; Meltzer H Y
Serum creatine phosphokinase activity in psychiatrically hospitalized children.
Archives of general psychiatry 1976;33(6):679-81.
1976: Meltzer H Y; Cho H W; Carroll B J; Russo P
Serum dopamine-beta-hydroxylase activity in the affective psychoses and schizophrenia. Decreased activity in unipolar psychotically depressed patients.
Archives of general psychiatry 1976;33(5):585-91.
1976: Meltzer H Y
Skeletal muscle necrosis following membrane-active drugs plus serotonin.
Journal of the neurological sciences 1976;28(1):41-56.
1976: Meltzer H Y; Belmaker R; Wyatt R J; Pollin W; Cohen S
Serum creatine phosphokinase (CPK) activity in monozygotic twins discordant for schizophrenia: heritability of serum CPK activity.
Comprehensive psychiatry 1976;17(3):469-75.
1976: Meltzer H Y; Fang V S
The effect of neuroleptics on serum prolactin in schizophrenic patients.
Archives of general psychiatry 1976;33(3):279-86.
1976: Meltzer H Y
Serum creatine phosphokinase in schizophrenia.
The American journal of psychiatry 1976;133(2):192-7.
1976: Meltzer H Y; Fang V S
Effect of apomorphine plus 5-hydroxytryptophan on plasma prolactin levels in male rats.
Psychopharmacology communications 1976;2(3):189-98.
1976: Meltzer H Y; Stahl S M
The dopamine hypothesis of schizophrenia: a review.
Schizophrenia bulletin 1976;2(1):19-76.
1976: Meltzer H Y
Neuromuscular dysfunction in schizophrenia.
Schizophrenia bulletin 1976;2(1):106-35.
1976: Meltzer H Y
Biochemical studies in schizophrenia.
Schizophrenia bulletin 1976;2(1):10-8.
1975: Meltzer H Y
Plasma creatine phosphokinase levels in rats following lysergic acid diethylamide.
Psychopharmacologia 1975;44(1):91-3.
1975: Meltzer H Y; Daniels S; Fang V S
Clozapine increases rat serum prolactin levels.
Life sciences 1975;17(3):339-42.
1975: Fang V S; Cho H W; Meltzer H Y
Labeling of creatine phosphokinase without loss of enzyme activity.
Biochemical and biophysical research communications 1975;65(1):413-9.
1975: Strahilevitz M; Narasimhachari N; Fischer G W; Meltzer H Y; Himwich H E
Indolethylamine-N-methyltransferase activity in psychiatric patients and controls.
Biological psychiatry 1975;10(3):287-302.
1975: Meltzer H Y
Letter: serum creatine kinase in acute psychosis.
The British journal of psychiatry : the journal of mental science 1975;126():489-90.
1975: Meltzer H Y; Hassan S Z; Moretti R; Hengeveld C; Bruckner D
Letter: Effect of ketamine on creatine phosphokinase levels.
Lancet 1975;1(7917):1195-6.
1975: Goode D J; Meltzer H Y
The role of isometric muscle tension in the production of muscle toxicity by phencyclidine and restraint stress.
Psychopharmacologia 1975;42(1):105-8.
1975: Pscheidt G R; Meltzer H Y
Letter: Lithium and pyruvate kinase.
Lancet 1975;1(7912):932.
1975: Meltzer H Y
Lack of effect of ouabain on creatine phosphokinase efflux from skeletal muscle.
Biochemical pharmacology 1975;24(3):419-21.
1975: Meltzer H Y; Sachar E J; Frantz A G
Dopamine antagonism by thioridazine in schizophrenia.
Biological psychiatry 1975;10(1):53-7.
1975: Kanner M; Finnegan K; Meltzer H Y
Dopaminergic effects of phencyclidine in rats with nigrostriatal lesions.
Psychopharmacology communications 1975;1(4):393-401.
1975: Meltzer H Y; Crayton J W
Neuromuscular abnormalities in the major mental illnesses. II. Muscle fiber and subterminal motor nerve abnormalities.
Research publications - Association for Research in Nervous and Mental Disease 1975;54():189-207.
1975: Meltzer H Y
Neuromuscular abnormalities in the major mental illnesses. I. Serum enzyme studies.
Research publications - Association for Research in Nervous and Mental Disease 1975;54():165-88.
1974: Kuncl R W; Meltzer H Y
Pathologic effect of phencyclidine and restraint on rat skeletal muscle structure: prevention by prior denervation.
Experimental neurology 1974;45(2):387-402.
1974: Meltzer H Y; Sachar E J; Frantz A G
Serum prolactin levels in unmedicated schizophrenic patients.
Archives of general psychiatry 1974;31(4):564-9.
1974: Cho H W; Meltzer H Y
Mg++-dependent adenosine triphosphatase activity in erythrocyte ghosts of schizophrenic patients.
Biological psychiatry 1974;9(2):109-16.
1974: Goode D J; Meltzer H Y
Cytotoxic effects of imipramine on platelets.
Biochemical pharmacology 1974;23(18):2629-35.
1974: Holzman P S; Proctor L R; Levy D L; Yasillo N J; Meltzer H Y; Hurt S W
Eye-tracking dysfunctions in schizophrenic patients and their relatives.
Archives of general psychiatry 1974;31(2):143-51.
1974: Meltzer H Y
Letter: Creatine phosphokinase and psychiatric illness.
The British journal of psychiatry : the journal of mental science 1974;125(0):219-20.
1974: Meltzer H Y
Letter: Interpretation of CPK activity.
JAMA : the journal of the American Medical Association 1974;229(9):1169.
1974: Meltzer H Y; Holy P A
Black-white differences in serum creatine phosphokinase (CPK) activity.
Clinica chimica acta; international journal of clinical chemistry 1974;54(2):215-24.
1974: Meltzer H Y; Sachar E J; Frantz A G
Proceedings: Serum prolactin levels in newly admitted psychiatric patients.
Psychopharmacology bulletin 1974;10(3):14-5.
1974: Meltzer H Y; Crayton J W
Subterminal motor nerve abnormalities in psychotic patients.
Nature 1974;249(455):373-5.
1974: Meltzer H Y; Crayton J W
Muscle abnormalities in psychotic patients. II. Serum CPK activity, fiber abnormalities, and branching and sprouting of subterminal nerves.
Biological psychiatry 1974;8(2):191-208.
1974: Meltzer H Y; Stahl S M
Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients.
Research communications in chemical pathology and pharmacology 1974;7(2):419-31.
1974: Meltzer H Y; Sachar E J; Frantz A G
Serum prolactin levels in newly admitted psychiatric patients.
Advances in biochemical psychopharmacology 1974;12(0):299-315.
1973: Meltzer H Y
Creatine phosphokinase activity and clinical symptomatology. A study in acute schizophrenic patients.
Archives of general psychiatry 1973;29(5):589-93.
1973: Goode D J; Dekirmenjian H; Meltzer H Y; Maas J W
Relation of exercise to MHPG excretion in normal subjects.
Archives of general psychiatry 1973;29(3):391-6.
1973: Meltzer H Y
Plasma creatine phosphokinase activity in the rat after tenotomy or denervation.
Experimental neurology 1973;40(2):547-51.
1973: Meltzer H Y
Morphological effects of Compound 48-80, polymyxin B sulfate, and dextran on rat skeletal muscle.
Archives of pathology 1973;96(2):118-23.
1973: Meltzer H Y; McBride E; Poppei R W
Rod (nemaline) bodies in the skeletal muscle of an acute schizophrenic patient.
Neurology 1973;23(7):769-80.
1973: Meltzer H Y
Skeletal muscle abnormalities in patients with affective disorders.
Journal of psychiatric research 1973;10(1):43-57.
1973: Meltzer H Y; Margulies P; Cho H W
Release of creatine phosphokinase from muscle. II. Effect of multiple doses of polymyxin B or compound 48-80 on increases in plasma enzyme levels.
Biochemical pharmacology 1973;22(7):857-63.
1973: Meltzer H Y
Serum creatine phosphokinase activity in acute psychosis.
The British journal of psychiatry : the journal of mental science 1973;122(568):369.
1973: Meltzer H Y
Effect of theophylline on alkaline phosphatase activity of denervated skeletal muscle fibers.
Research communications in chemical pathology and pharmacology 1973;5(2):539-42.
1973: Meltzer H Y
Effects of phencyclidine and restraint at 2 degrees C on rat plasma creatine phosphokinase activity.
Research communications in chemical pathology and pharmacology 1973;5(1):117-27.
1973: Meltzer H Y
Rigidity, hyperpyrexia and coma following fluphenazine enanthate.
Psychopharmacologia 1973;29(4):337-46.
1972: Meltzer H Y
Central core fibers in an acutely psychotic patient. Evidence for a neurogenic basis for the muscle abnormalities in the acute psychoses.
Archives of general psychiatry 1972;27(1):125-32.
1972: Meltzer H Y
Muscle toxicity produced by phencyclidine and restraint stress.
Research communications in chemical pathology and pharmacology 1972;3(2):369-82.
1972: Meltzer H Y; Holzman P S; Hassan S Z; Guschwan A
Effects of phencyclidine and stress on plasma creatine phosphokinase (CPK) and aldolase activities in man.
Psychopharmacologia 1972;26(1):44-53.
1971: Meltzer H Y; Margulies P
Release of creatine phosphokinase from muscle. I. Effect of polymyxin B, compound 48-80, and serotonin.
Biochemical pharmacology 1971;20(12):3501-8.
1971: Meltzer H Y
Plasma creatine phosphokinase activity, hypothermia, and stress.
The American journal of physiology 1971;221(3):896-901.
1971: Meltzer H Y; Nankin R; Raftery J
Serum creatine phosphokinase activity in newly admitted psychiatric patients. II.
Archives of general psychiatry 1971;24(6):568-72.
1971: Meltzer H Y
Factors affecting serum creatine phosphokinase levels in the general population: the role of race, activity and age.
Clinica chimica acta; international journal of clinical chemistry 1971;33(1):165-72.
1971: Narasimhachari N; Heller B; Spaide J; Haskovec L; Meltzer H; Strahilevitz M; Himwich H E
N,N-dimethylated indoleamines in blood.
Biological psychiatry 1971;3(1):21-3.
1970: Meltzer H Y; Moline R
Muscle abnormalities in acute psychoses.
Archives of general psychiatry 1970;23(6):481-91.
1970: Meltzer H Y; Engel W K
Histochemical abnormalities of skeletal muscle in acutely psychotic patients. II.
Archives of general psychiatry 1970;23(6):492-502.
1970: Fischman D A; Meltzer H Y; Poppei R W
Disruption of myofibrils in the skeletal muscle of psychotic patients.
Archives of general psychiatry 1970;23(6):503-15.
1970: Meltzer H Y; Grinspoon L; Shader R I
Serum creatine phosphokinase and aldolase activity in acute schizophrenic patients and their relatives.
Comprehensive psychiatry 1970;11(6):552-8.
1970: Kupfer D J; Meltzer H Y; Wyatt R J; Snyder F
Serum enzyme changes during sleep deprivation.
Nature 1970;228(5273):768-70.
1970: Meltzer H
Increased activity of creatine phosphokinase and aldolase activity in the acute psychoses: case reports.
Journal of psychiatric research 1970;7(4):249-62.
1970: Meltzer H Y; Moline R
Plasma enzymatic activity after exercise. Study of psychiatric patients and their relatives.
Archives of general psychiatry 1970;22(5):390-7.
1970: Meltzer H Y; Kupfer D J; Wyatt R; Snyder F
Sleep disturbance and serum CPK activity in acute psychosis.
Archives of general psychiatry 1970;22(5):398-405.
1970: Engel W K; Meltzer H
Histochemical abnormalities of skeletal muscle in patients with acute psychoses.
Science (New York, N.Y.) 1970;168(928):273-6.
1970: Meltzer H Y; Mrozak S; Boyer M
Effect of intramuscular injections on serum creatine phosphokinase activity.
The American journal of the medical sciences 1970;259(1):42-8.
1969: Meltzer H Y; Boyer M
Effect of blood serum or plasma from schizophrenic patients and others on an action of 3,4-dimethoxyphenylethylamine: a failure to replicate.
Archives internationales de pharmacodynamie et de thérapie 1969;182(2):481-8.
1969: Meltzer H
Muscle enzyme release in the acute psychoses.
Archives of general psychiatry 1969;21(1):102-12.
1969: Meltzer H
Intramuscular chlorpromazine and creatine kinase: acute psychoses or local muscle trauma?
Science (New York, N.Y.) 1969;164(880):726-7.
1969: Meltzer H; Shader R; Grinspoon L
The behavioral effects of nicotinamide adenine dinucleotide in chronic schizophrenia.
Psychopharmacologia 1969;15(2):144-52.
1968: Meltzer H
Creatine kinase and aldolase in serum: abnormality common to acute psychoses.
Science (New York, N.Y.) 1968;159(821):1368-70.
1962: MELTZER H Y
The effect of pyridine aldoxime dodecyliodide on monamine oxidase and bound amines.
Biochemical pharmacology 1962;11():617-25.
1961: MELTZER H Y
The effect of thiamine on monoamine oxidase.
Biochemical pharmacology 1961;7():277-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Herbert Meltzer

Research Profile (preview)

Disorders

Chemicals & Drugs

Living Beings

Activities & Behaviors

Concepts & Ideas

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Herbert Meltzer (preview)

All Publications